WO1999045838A1 - Optical biopsy system and methods for tissue diagnosis - Google Patents
Optical biopsy system and methods for tissue diagnosis Download PDFInfo
- Publication number
- WO1999045838A1 WO1999045838A1 PCT/US1999/005134 US9905134W WO9945838A1 WO 1999045838 A1 WO1999045838 A1 WO 1999045838A1 US 9905134 W US9905134 W US 9905134W WO 9945838 A1 WO9945838 A1 WO 9945838A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tissue
- endoscope
- diagnosis
- intensity
- fluorescence
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/06—Biopsy forceps, e.g. with cup-shaped jaws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
- A61B1/042—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances characterised by a proximal camera, e.g. a CCD camera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
- A61B1/043—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances for fluorescence imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0066—Optical coherence imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
Definitions
- Tissue diagnosis is important in many fields of medicine, including, but not limited to: gastrointestinal, cardiovascular, uro logical, pulmonary, reproductive, dermatology, surgery, and general medicine. For example, early detection of tissue malignancy is essential to avoid the spread of cancer and associated complications.
- endoscopic and/or laparoscopic "minimally invasive" techniques can be used to obtain a biopsy that provides a physical sample of a tissue site.
- the tissue site can be either a flat surface or subsurface mucosal lesion or a raised mucosal lesion (e.g., a polyp).
- the biopsy can be analyzed in a pathology laboratory using histopathological techniques to determine whether it is cancerous.
- the tissue may be normal, hyperplastic, adenomatous, or malignant.
- hyperplastic polyps consist of normal tissue, and are therefore benign.
- Adenomatous polyps which are also referred to as dysplastic polyps, consist of 2 abnormal tissue, and are a risk of future malignancy.
- Adenocarcinomas are malignant polyps that pose an immediate risk of spreading to other areas of the body.
- Histopathology while relatively accurate, requires the physical removal of a tissue sample and its time-consuming analysis in a pathology laboratory. Further treatment of the tissue site based on the results of the histopathological analysis may require a second medical procedure, separate from the original diagnostic procedure that obtained the biopsy. Along with an increased cost and patient discomfort, locating the original biopsy site may be extremely difficult. Moreover, gathering a physical biopsy sample is not without risk, since it typically involves cutting and removing a small portion of tissue. For this reason, taking unnecessary physical biopsy samples should be avoided. Sampled tissue sites that are subsequently found to be hyperplastic by histopathological analysis were, in retrospect, unnecessarily sampled.
- some patients undergoing endoscopic colonic examination will have an abundance of small (e.g., less than 5 millimeters in diameter) polyps that are either hyperplastic or adenomatous. Since sampling each site is difficult and increases the risk of other complications, physical samples are obtained from only a "representative" subpopulation of the sites. However, this leaves other possibly premalignant sites undiagnosed, even though such sites could become malignant and contribute to the spread of cancer in the patient. Thus, the risk of obtaining physical biopsy samples is compounded when only a subpopulation of the sites is sampled.
- an endoscopist In deciding whether to remove a physical biopsy sample for histopathological analysis, an endoscopist typically subjectively determines visually whether a polyp is hyperplastic or adenomatous.
- the accuracy of existing biopsy methods depends upon the endoscopist's ability to subjectively determine healthy from suspicious tissue to biopsy.
- an accurate visual characterization is extremely difficult, and histopathological analysis of a physical tissue sample is often required. As a 3 result, the subjective visual inspection may leave adenomatous polyps undiagnosed and therefore untreated.
- tissue classification techniques have also been developed as alternatives or adjuncts to physical biopsy sampling and visual differentiation between tissue characteristics.
- One class of such techniques involves illuminating tissue with incident light, and allowing the incident light energy to interact with the tissue. The tissue is classified based on light that is returned from the tissue.
- a particularly interesting class of such techniques referred to as fluorescence spectroscopy, is based on the observation that different tissue characteristics result in a different fluorescence in the returned light. More particularly, spectral characteristics of the fluorescence returned from premalignant or malignant tissue may be different from that returned from normal or benign tissue.
- Contrast agents are typically substances that are ingested by the patient, delivered intravenously, or delivered locally to a tissue site to enhance its fluorescence.
- a contrast agent is known to substantially target only the particular type of tissue being detected, and to increase the fluorescence properties of that type of tissue for obtaining a better image.
- Contrast agents pose at least two problems. First, their selectivity is less than optimal. Tissue uptake and concentration levels may be significantly variable. The contrast agent attaches to other types of tissue as well as the targeted tissue. This hinders an accurate diagnosis based on observation of returned fluorescence. Second, certain contrast agents have undesirable side-effects, such as acute and/or chronic light-sensitivity of the patient. Thus, fluorescence techniques using extrinsic fluorescence-enhancing agents for diagnosis have limited usefulness.
- extrinsic fluorescence-enhancing agents depending instead on native fluorescence (also referred to as autofluorescence) from endogenous tissue.
- native fluorescence also referred to as autofluorescence
- the spectral characteristics of the fluorescence returned from premalignant or malignant tissue may be different from that returned from normal or benign tissue.
- Such differences are much less pronounced in the absence of 4 extrinsic image contrast agents. Detecting small differences between spectral fluorescence characteristics of different tissue types is much more difficult without using extrinsic image contrast agents.
- such systems require complicated and expensive components, such as multiple optical fibers for illuminating or collecting returned fluorescence from the tissue, or image intensification or photomultiplication devices for obtaining an adequate signal from the returned fluorescence.
- the diagnosing optics are removed from the working channel of an endoscope so that a forceps, snare, or ablation device can be extended through the working channel of an endoscope to treat the tissue.
- exchanging diagnostic and treatment devices poses problems.
- inherent colonic motility makes it difficult for the physician to accurately maintain the position of the endoscope during the exchange of diagnosing and treatment devices.
- the physician may not be able to locate the previously diagnosed polyp or may inadvertently treat the wrong polyp.
- exchanging diagnosing and treatment devices reduces the efficacy of the medical procedure.
- the present invention provides, among other things, systems, devices, and methods for accurate tissue characterization, without requiring the use of extrinsic fluorescence enhancing agents, and immediate treatment of the tissue based on the tissue characterization.
- the invention includes a method.
- An endoscope having viewing optics and a conduit (such as a
- working channel of the endoscope is introduced into a living organism.
- a diagnostic optical fiber is introduced through the conduit into proximity with tissue at a distal end of the endoscope.
- Excitation electromagnetic energy is transmitted through the diagnostic optical fiber to the tissue without requiring fluorescence-enhancing agents.
- Electromagnetic energy is received through the diagnostic optical fiber from the tissue in response to the excitation electromagnetic energy.
- a diagnosis of the tissue is provided using an analysis of a signal that is based on the received electromagnetic energy. The tissue is treated, if indicated by the diagnosis, while the diagnostic optical fiber is still in the conduit of the endoscope.
- Treating the tissue consists essentially of at least one of the following: taking a physical biopsy sample of at least a portion of the tissue, mechanically removing at least a portion of the tissue, performing electrosurgery on at least a portion of the tissue, delivering a drug or other chemical agent to at least a portion of the tissue, and providing photodynamic therapy to at least a portion of the tissue.
- transmitting excitation electromagnetic energy includes activating a light source using a switch that is located on the endoscope.
- the light source is voice-actuated.
- providing a diagnosis of the tissue includes forming an intensity spectrum of the received electromagnetic energy.
- a diagnosis probability is computed based on intensities at particular wavelengths in the intensity spectrum.
- the diagnosis probability is compared to a threshold probability to characterize the tissue.
- comparing the diagnosis 6 probability to a threshold probability includes basing at least one of the diagnosis probability and the threshold probability on a logistics regression analysis, multivariate linear regression analysis (MVLR), stepwise regression analysis, best subset analysis, spectral peaks(s) ratio analysis, neural network analysis, or other analysis of data obtained from other tissue samples.
- MVLR multivariate linear regression analysis
- providing the diagnosis of the tissue includes forming the diagnosis based on a slope of the intensity spectrum at particular wavelengths. In a further embodiment, providing the diagnosis of the tissue includes forming the diagnosis based on a curvature of the intensity spectrum at particular wavelengths.
- the method includes normalizing the intensity spectrum to a reference intensity spectrum by dividing each intensity at a particular wavelength in the intensity spectrum by an intensity at the corresponding wavelength in the reference intensity spectrum.
- the intensity spectrum is normalized by dividing each intensity at a particular wavelength in the intensity spectrum by a sum of intensities over a range of wavelengths in the intensity spectrum.
- the intensity spectrum is corrected by subtracting a background reading.
- subtracting a background reading includes correcting for endoscope light.
- C is a constant
- I is a detected return fluorescence intensity at a particular wavelength
- B is a constant corresponding to the particular wavelength
- n is any positive integer.
- the probability factor P is compared to a predetermined value to diagnose the tissue.
- C, B, and P are based on a logistics regression analysis of data obtained from other tissue samples.
- C is a constant
- I is a detected return fluorescence intensity at a particular wavelength
- B is a constant corresponding to the particular wavelength
- n is any positive integer.
- the score S is compared to a predetermined threshold value to diagnose the tissue.
- at least one of C, B, and the predetermined threshold value are based on at least one of: logistics regression analysis, multivariate linear regression (MVLR) analysis, stepwise regression analysis, best subset analysis, spectral peak(s) ratio analysis, and neural network analysis.
- MVLR multivariate linear regression
- providing a diagnosis of the tissue includes forming a score X, wherein: n
- C is a constant corresponding to the particular wavelength
- S is a slope of the detected return fluorescence intensity spectrum at a particular wavelength
- n is any positive integer.
- the score X is compared to a predetermined threshold value to diagnose the tissue.
- at least one of C and the predetermined threshold value are based on at least one of: logistics regression analysis, multivariate linear regression (MVLR) analysis, stepwise regression analysis, best subset analysis, spectral peak(s) ratio analysis, and neural network analysis.
- MVLR multivariate linear regression
- providing a diagnosis of the tissue includes forming a score X, wherein:
- the score X is compared to a predetermined threshold value to diagnose the tissue.
- one of the above-described tissue diagnosis techniques is used in combination with another tissue diagnosis technique, such as at least one of: optical coherent tomography, interferometiy, optical-acoustic imaging, acoustic-optical imaging, fluorescence imaging, photomigration, time- resolved fluorescence spectroscopy, frequency-domain fluorescence spectroscopy, elastic scattering, Rayleigh scattering, Raman scattering, and other linear or nonlinear optical techniques.
- the method includes providing an audible or visual indicator of the diagnosis such as, for example, displaying an intensity vs. wavelength graph or one or more icons or other audible or visual indicators of whether the characterized tissue should be further treated.
- the indicator overlays a visual image of the tissue displayed on an endoscope monitor.
- the method includes correcting the signal that is based on the received electromagnetic excitation energy by subtracting a background reading.
- subtracting the background reading includes, among other things, correcting for endoscope light.
- Another aspect of the invention provides, among other things, a second method.
- the method includes introducing into a living organism an endoscope having viewing optics and a conduit. A view at the distal end of the endoscope is displayed on an endoscope monitor. A diagnostic optical fiber is introduced through the conduit into proximity with tissue at the distal end of the endoscope. Electromagnetic excitation energy is transmitted through the diagnostic optical fiber to the tissue. Electromagnetic energy is received through the diagnostic optical fiber from the tissue in response to the excitation electromagnetic energy. A diagnosis of the tissue is provided. The diagnosis is based on an analysis of the received electromagnetic energy. An indicator of the diagnosis is displayed on the endoscope monitor. In one embodiment, displaying an indicator of the diagnosis includes displaying the indicator together with a visual image of the tissue displayed on the endoscope monitor.
- An endoscope including viewing optics and a conduit, is introduced into a living organism.
- a diagnostic optical fiber is introduced through the conduit into proximity with tissue at a distal end of the endoscope.
- a video image of the tissue is obtained and digitally enhanced.
- a tissue site is located based on the enhanced video image of the tissue.
- Excitation electromagnetic energy is transmitted through the diagnostic optical fiber to the located tissue site without requiring fluorescence-enhancing agents.
- Electromagnetic energy is received through the diagnostic optical fiber from the tissue site in response to the excitation electromagnetic energy.
- a diagnosis of the tissue site is provided using an analysis of a signal that is based on the received electromagnetic energy.
- Treating the tissue site consists essentially of at least one of the following: taking a physical biopsy sample of at least a portion of the tissue site, mechanically removing at least a portion of the tissue site, performing electrosurgery on at least a portion of the tissue site, delivering a drug or other chemical agent to at least a portion of the tissue site, and providing photodynamic therapy to at least a portion of the tissue.
- Another aspect of the invention provides, among other things, a fourth method. An endoscope having viewing optics and a working channel conduit is introduced into a patient's colon, for example.
- a diagnostic optical fiber and coaxially integrated forceps is introduced through the conduit into proximity with tissue at a distal end of the endoscope.
- Excitation light pulses are generated.
- the excitation light pulses are coupled to the diagnostic optical fiber using a dichroic mirror.
- the excitation light pulses are transmitted through the diagnostic fiber to the tissue without requiring fluorescence-enhancing agents.
- Return light is received through the diagnostic optical fiber from the tissue in response to the excitation light pulses.
- the return light is filtered to obtain a return fluorescence light by removing components of the return light having a wavelength that is approximately shorter than approximately 355 nanometers.
- the filtered return light is spatially separated to obtain a return fluorescence spectrum.
- the intensity of the return fluorescence spectrum is detected at a 10 plurality of wavelengths.
- the detected return fluorescence intensity spectrum is corrected by subtracting a background reading.
- the probability factor P is compared to a predetermined value to diagnose the tissue.
- An indicator of the diagnosis is displayed on an endoscope monitor, together with a visual image of the tissue.
- a physical biopsy sample of the tissue is taken, if indicated by the diagnosis, while the diagnostic optical fiber is still in the working channel conduit of the endoscope.
- the system includes an electromagnetic excitation energy source.
- a single diagnostic optical fiber is adapted to extend through a conduit in an endoscope, from a proximal end of the endoscope to a distal end of the endoscope.
- the diagnostic optical fiber transmits the electromagnetic excitation energy to a tissue and receiving an electromagnetic response from the tissue at the distal end of the endoscope.
- a spectrophotometer receives the electromagnetic response and provides a resulting spectral response signal.
- An optical coupler couples the electromagnetic excitation energy from the energy source to the diagnostic optical fiber, and coupling the electromagnetic response to the spectrophotometer.
- a diagnosis module receives the spectral response signal and provides a resulting tissue classification without requiring fluorescence- enhancing agents at the tissue.
- a tissue treatment apparatus is integrally formed with the diagnostic optical fiber. The tissue treatment apparatus is selected from the group consisting essentially of: a biopsy forceps, a biopsy needle, a polyp snare, an radio-frequency (RF) ablation apparatus, an electrosurgical apparatus, a photodynamic therapy (PDT) apparatus, a drug or chemical agent delivery apparatus, a guidewire, and a catheter. 11
- the optical coupler includes a mirror for reflectively coupling the electromagnetic excitation energy to the diagnostic optical fiber.
- the optical coupler also includes at least one lens for coupling the electromagnetic response to the spectrophotometer.
- the system also includes an interface circuit.
- the interface circuit is adapted for displaying an indicator of at least one of the spectral response signal and the tissue classification to an endoscope monitor.
- the interface circuit is adapted for receiving a video signal image of the tissue at the distal end of the endoscope, and adapted for providing the video signal image together with an indicator of the tissue classification to an endoscope monitor.
- the interface circuit further comprises an image enhancement module, coupled to the interface circuit, for enhancing the video signal image of the tissue at the distal end of the endoscope.
- the tissue treatment apparatus is coaxially formed with the single diagnosing optical fiber concentrically located at the center of the tissue treatment apparatus.
- the electromagnetic excitation energy source is coupled to and actuated by a switch that is located on the endoscope.
- the electromagnetic excitation energy source is voice-actuated.
- Another aspect of the invention provides a second system for analyzing, diagnosing, and treating tissue.
- the system includes a pulsed laser, with or without a wavelength-shifting dye module, providing electromagnetic excitation energy.
- a single diagnostic optical fiber is adapted to extend through a working channel conduit in an endoscope, from a proximal end of the endoscope to a distal end of the endoscope, for transmitting the electromagnetic excitation energy to and receiving an electromagnetic response from a colonic tissue site at the distal end of the endoscope.
- the single diagnostic fiber is coaxially and concentrically integrally formed within a treatment apparatus.
- the tissue treatment apparatus is selected from a group that consists essentially of: a biopsy forceps, a biopsy needle, a polyp snare, an radio-frequency (RF) ablation apparatus, an electrosurgical apparatus, a photodynamic therapy (PDT) apparatus, a drug or chemical agent delivery apparatus, a guidewire, and a catheter.
- RF radio-frequency
- PDT photodynamic therapy
- a spectrophotometer receives the electromagnetic response and 12 provides a resulting spectral response signal.
- the spectrophotometer includes a spectrograph for providing spatial dispersion of the spectral response signal.
- the spectrophotometer also includes an optical detector for detecting the spatially dispersed spectral response signal.
- the spectrophotometer further includes a thermoelectric cooler for regulating the temperature of the optical detector.
- the system further includes an optical coupler, coupling the electromagnetic excitation energy from the pulsed laser to the diagnostic optical fiber, and coupling the electromagnetic response to the spectrophotometer.
- the optical coupler includes a dichroic mirror for reflectively coupling the electromagnetic excitation energy to the diagnostic optical fiber.
- the optical coupler also includes at least one lens for coupling the electromagnetic response to the spectrophotometer.
- the system also includes a diagnosis module.
- the diagnosis module receives the spectral response signal and provides a resulting tissue classification without requiring fluorescence-enhancing agents at the tissue.
- the diagnosis module also includes an executable sequence of instructions for classifying the tissue.
- the system also includes an interface circuit for receiving a video signal image of the tissue at the distal end of the endoscope.
- the interface circuit is adapted for providing the video signal image together with an indicator of the tissue classification to an endoscope monitor.
- the system further includes an image enhancement module, coupled to the interface circuit, for enhancing the video signal image of the tissue at the distal end of the endoscope.
- Figure 1A illustrates generally one embodiment of portions of an endoscopic system for tissue diagnosis and the environment in which it is used.
- Figure IB illustrates generally another embodiment of portions of an endoscopic system for tissue diagnosis and the environment in which it is used.
- Figure 2 is a block diagram illustrating generally one embodiment of an optical configuration of portions of the present invention.
- Figure 3 A is a block diagram illustrating generally one embodiment of a hardware configuration for performing signal processing and diagnosis for tissue classification.
- Figure 3B is a block diagram illustrating generally another embodiment of a hardware configuration that includes image enhancement capability.
- Figure 4 is a flow chart illustrating generally an overview of one embodiment of using the present invention for characterizing or diagnosing tissue.
- Figure 5 is a flow chart illustrating generally one embodiment of steps included in performing startup procedures.
- Figure 6 is a flow chart illustrating generally one embodiment of techniques for tissue diagnosis.
- Figure 7 is a flow chart illustrating generally an alternative embodiment of techniques for tissue diagnosis.
- Figure 8 is a graph illustrating generally intensity vs. wavelength from colonic tissue that is normal, hyperplastic, and adenomatous.
- Figure 9 is a flow chart illustrating generally one method of diagnosing patients with lower gastrointestinal symptoms. Detailed Description of the Invention
- distal refers to a direction toward an end inserted into the patient.
- Proximal refers to a direction toward an end remaining outside the patient.
- Negative fluorescence and “autofluorescence” refer to fluorescence from tissue not treated with dyes, stains, or other image contrast agents used to enhance the fluorescence characteristics of tissue.
- Endogenous tissue refers to tissue not treated with dyes stains, or other image contrast agents, such that its fluorescence characteristics are inherent to the tissue itself.
- Endoscope and “endoscopic” includes generally, but is not limited to, any instrument for examining interior portions of a living organism, including laparoscopic instruments and techniques.
- Endoscope includes a fiberscope, having at least one optical fiber for delivering white light to the tissue and having at least one optical fiber for transmitting a resulting image of the tissue to a camera.
- Endoscope also includes a digital endoscope, having at least one optical fiber for delivering white light to the tissue, and having an optical detector in close proximity with the tissue for receiving a visual image and providing a resulting electrical video signal to a monitor or computer.
- “Treatment” includes the taking of a physical biopsy sample with a forceps, needle, or other instrument, removal of tissue with a snare or other instrument, ablation and/or electrocautery of the tissue using radio-frequency (RF) energy, delivery of a drug or other chemical agent to the tissue, photodynamic therapy (PDT) including delivering light to activate a drug or chemical agent at or in the tissue, and treatment using a guidewire and catheter.
- RF radio-frequency
- PDT photodynamic therapy
- Biopsy includes both taking a physical sample, such as for histopathological analysis, or otherwise characterizing or classifying the tissue, 15 such as by using optical or other techniques.
- Optical biopsy includes characterizing or classifying a portion of a living organism by using optical techniques instead of by taking a physical sample.
- “Spectrograph” includes any device providing, across a spectrum of wavelengths, spatial separation or dispersion of electromagnetic intensities.
- “Spectrophotometer” includes any instrument that provides a signal indicating a spectral electromagnetic intensity across a range of wavelengths, and may include, as one of its components, a spectrograph.
- Figure 1A illustrates generally one embodiment of portions of an endoscopic system for tissue diagnosis using native fluorescence, and the environment in which it is used, according to one aspect of the present invention.
- Figure 1A includes an endoscope 100 for examining the interior of a patient's respiratory tract, upper or lower gastrointestinal tract, or urinary tract. Many commercially available endoscopes 100 will be suitable for use according to the present invention.
- Endoscope 100 includes a proximal end 105, a distal end 110, and viewing optics 115.
- Viewing optics 115 includes an optical fiber extending through endoscope 100 for providing illumination at distal end 110.
- Viewing optics 115 also includes, in one embodiment, an optical fiber extending through endoscope 100 for viewing, at proximal end 105, the image at distal end 110.
- viewing optics 115 includes an optical detector at distal end 110 of endoscope 100, providing an electrical video signal that is communicated to the proximal end 105 of endoscope 100.
- Working channel 120 provides a conduit between proximal end 105 and distal end 110 through which various endoscopic accessories can be inserted.
- Figure 1A illustrates, by way of example, but not by way of limitation, one such endoscopic accessory, an integrated diagnosis and treatment device 125, extending through working channel 120 of endoscope 100 for classifying and treating tissue 130.
- device 125 includes an optical biopsy forceps, such as described in one of the following co-pending, commonly assigned U.S. patent applications: Application Number 08/644,080 entitled “OPTICAL BIOPSY FORCEPS,” filed on 5/7/1996, Application Number 08/975,734 entitled “OPTICAL BIOPSY FORCEPS,” filed on 11/21/1997, 16
- device 125 includes a photodynamic therapy
- device 125 includes, by way of example, but not by way of limitation a polyp snare, a radio-frequency (RF) ablation apparatus, an electrosurgery apparatus, a drug or chemical agent delivery apparatus, and a guidewire and catheter. Examples of guidewires and catheters are described in Gunderson et al. U.S. Patent Number 5,601,087 entitled "SYSTEM FOR DIAGNOSING TISSUE WITH GUIDEWIRE,” Gunderson et al.
- RF radio-frequency
- the optical biopsy forceps includes a diagnosing optical fiber 135 for contacting tissue 130 at distal end 110 of endoscope 100.
- the optical biopsy forceps also includes an integrated tissue treatment device, such as forceps 140. Using forceps 140, a physical biopsy sample of tissue 130 is taken if indicated by the diagnosis of tissue 130.
- forceps 140 is operatively controlled by wires extending through working channel 120 and coupled to portions of handle 145 near the proximal end 105 of endoscope 100. By manipulating finger pieces 150A-B or other levers on handle 145, opposing jaws of forceps 140 are opened and closed. Diagnostic optical fiber 135 is coupled to console 155, or any other suitable apparatus for carrying components needed for diagnosing, characterizing, or otherwise classifying tissue 130 using electromagnetic energy.
- console 155 also includes high resolution (e.g., 1024 x 768 17 pixels) user display 160 and one or more user input devices such as, for example, keyboard 165, mouse 170, and footswitch 175, or switch located on endoscope 100, or microphone for voice-actuation of a diagnostic procedure.
- high resolution e.g., 1024 x 768 17 pixels
- user display 160 and one or more user input devices such as, for example, keyboard 165, mouse 170, and footswitch 175, or switch located on endoscope 100, or microphone for voice-actuation of a diagnostic procedure.
- user input devices such as, for example, keyboard 165, mouse 170, and footswitch 175, or switch located on endoscope 100, or microphone for voice-actuation of a diagnostic procedure.
- endoscope 100 further includes camera 180 for displaying a view at the distal end 110 of endoscope 100, obtained through viewing optics 115, on endoscope monitor 185.
- an electrical output signal also referred to as a video signal
- endoscope console endoscope instrument suite console
- a resulting video output signal from the endoscope computer is coupled to console 155, such as at node 191, before being directly or indirectly coupled at node 195 to endoscope monitor 185.
- Camera 180 may also be included in the rack-mounted accessory equipment and optically coupled to viewing optics 115 of endoscope 100 through an optical fiber.
- console 155 outputs a signal at node 195 to endoscope monitor 185 so that an audible or visual indicator of the tissue diagnosis can be provided (e.g., displayed on endoscope monitor 185 together with the view seen at the distal end 110 of endoscope 100).
- FIG. IB illustrates an alternative embodiment of portions of the endoscopic system and its environment.
- endoscope 100 is an example of a fiberscope, in which an optical signal is communicated from distal end 110 to proximal end 105 of endoscope through viewing optics 115. At proximal end 105, the optical signal is converted into an electrical video signal at node 190 by camera 180.
- endoscope 100 is an example of a digital endoscope 100, in which an image at distal end 110 is acquired by viewing optics that include a charge-coupled device (CCD) imaging integrated circuit (IC) 196, which is located at distal end 110 of endoscope 100.
- CCD charge-coupled device
- IC imaging integrated circuit
- Imaging IC 196 provides an electrical video signal that is communicated from distal end 110 to proximal end 105 of endoscope 100.
- the video signal is coupled, at node 190, to an endoscope computer in endoscope console 186.
- a video signal output from the endoscope computer is coupled to console 155 at node 191.
- console 155 overlays an indicator of the tissue characterization on the video signal, so that the video signal contains both the visual image of tissue 130 and the indicator of the tissue diagnosis performed by 18 console 155.
- This combined video signal is coupled at node 197 through the endoscope computer in endoscope console 186 and, at node 195, to the RGB video input of endoscope monitor 185.
- the combined video signal is coupled from console 155 directly to the RGB video input of endoscope monitor 185, as illustrated in Figure 1A.
- Optical Configuration Example Figure 2 is a block diagram illustrating generally one embodiment of an optical configuration of portions of the present invention.
- a coherent light source such as pulsed or continuous-wave laser 200, provides electromagnetic excitation energy ("excitation light").
- a noncoherent light source is used to provide excitation light, such as, for example, a Xenon flash bulb or an endoscope white light source used for illuminated viewing of tissue at the distal end 110 of endoscope 100.
- the excitation light is coupled to tissue 130 through aperture 205, optical coupler 21 , optical fiber 215, optical coupler 220, and through diagnostic optical fiber 135.
- return light is received from tissue 130 through diagnostic optical fiber 135, optical coupler 220, optical fiber 215, optical coupler 210, optical fiber 225.
- a component of this return light includes light-induced fluorescence electromagnetic energy (referred to as "return fluorescence").
- the return light also includes other components (e.g., reflected excitation light, and absorbed then scattered excitation light).
- the return fluorescence component of the return light is passed through filter 230 to a spectrophotometer, such as spectrograph 235.
- Spectrograph 235 spatially separates the spectral components of the return fluorescence for detection by optical detector 240.
- Optical detector 240 provides a resulting electrical data output signal at node 245 for analysis by a tissue characterization and diagnosis module, described below.
- Laser 200 provides excitation light having a wavelength that is approximately between 300 nanometers (nm) and 990 nm.
- laser 200 includes a pulsed nitrogen laser, with or without a wavelength-shifting dye module.
- laser 200 includes a Model 33799-01, or a Model 337ND, each available from Laser Science, Inc. of Franklin, MA.
- laser 200 provides excitation light having a wavelength of 19 approximately 337 nanometers (nm).
- Laser 200 delivers excitation light at a pulse rate that is approximately between 1 and 20 Hertz (e.g., at approximately 10 Hz).
- the pulsewidth of the excitation light includes a range that is approximately between 3 nanoseconds (ns) and 10 ns (e.g., 4 ns). In one embodiment, approximately between 1 and 100 pulses (e.g., approximately between 4-10 pulses) are used to perform a single classification of tissue 130. Other wavelengths, pulse rates, pulsewidths, and numbers of pulses could also be used.
- the light output from laser 200 is adjusted by aperture 205, which includes a mechanical aperture/iris that adjusts the beam size (e.g., a beam diameter that is approximately between 0 millimeters (mm) and 9 mm, such as at approximately 2 millimeters) to obtain a desired output power (e.g., approximately 10-60 microJoules, or greater, per pulse, or approximately 30-40 microJoules, or greater, per pulse).
- the beam size e.g., a beam diameter that is approximately between 0 millimeters (mm) and 9 mm, such as at approximately 2 millimeters
- a desired output power e.g., approximately 10-60 microJoules, or greater, per pulse, or approximately 30-40 microJoules, or greater, per pulse.
- optical coupler 210 includes mirror 250, lens 255, and lens 260.
- Mirror 250 is angularly positioned such that light received from laser 200 is reflected toward lens 255 (e.g., at a 90 degree angle).
- mirror 250 is a dichroic mirror (also referred to as a beamsplitter) that receives the light output by laser 200, and reflects only wavelengths of approximately 337 nanometers toward lens 255.
- dichroic mirror 250 is available from Omega Optical, Inc., of Brattleboro, VT, and provides approximately 95% reflection for incident light wavelengths less than approximately 350 nm and approximately 90 % transmission for incident light wavelengths that exceed approximately 350 nm.
- Lens 255 focuses the 337 nm incident light onto optical fiber 215.
- lens 255 is a plano-convex synthetic fused silica lens, such as a Model 01 LQP 001, available from Melles Griot of Irvine, CA.
- optical fiber 215 is a multimode optical fiber that is capable of transmitting a broad spectrum of light wavelengths, such as an H Series Optical Fiber available from Meteor Optics, Inc. of Glendale, AZ.
- Optical fiber 215 has an optically transmissive (e.g., fused silica) diameter of approximately between 75 and 600 micrometers ( ⁇ m) (e.g., 300 ⁇ m), a numerical aperture of NA ⁇ 0.22, 20 and is buffered with polyimide, silicone, acrylate, or any other suitable material.
- Optical fiber 215 is secured to optical coupler 210 by an optical fiber holder.
- the excitation light that is transmitted through optical fiber 215 is coupled to diagnostic optical fiber 135 by optical coupler 220, such as a Subminiature type A (SMA) 905 interface.
- Optical coupler 220 provides concentric alignment in its coupling of optical fiber 215 and diagnostic optical fiber 135.
- SMA Subminiature type A
- the excitation light is transmitted through diagnostic optical fiber 135 to tissue 130 at distal end 110 of endoscope 100.
- return light including a return fluorescence
- the return fluorescence wavelengths (e.g., approximately between 375 nm and 600 nm) exceed the excitation wavelength of 337 nm.
- the return light is transmitted through diagnostic optical fiber 135, optical coupler 220, and optical fiber 215 to optical coupler 210.
- the return light is collimated by lens 255. Since the return fluorescence has different wavelengths than those reflected by dichroic mirror 250, the return fluorescence is transmitted through dichroic mirror 250 to lens 260.
- Lens 260 focuses the return light onto optical fiber 225, which is secured to optical coupler 210 by an optical fiber holder.
- optical fiber 225 is a multimode optical fiber having an optically transmissive fused silica diameter of approximately 400 m. and a polyamide outer cladding. The larger diameter of optical fiber 225 allows for some misalignment with optical coupler 210 (e.g., inaccurate focus by lens 260 due to mechanical shock or vibration) in transmitting return light.
- optical coupler 210 includes adjustment knobs for adjusting the position of at least one of optical fibers 225 and 215 in relation to respective lenses 260 and 255, or vice-versa.
- Optical fiber 225 transmits the return light to filter 230.
- filter 230 is a long pass filter that substantially removes portions of the return light have wavelengths shorter than approximately 355 nm, including the reflected component of the excitation light at a wavelength of approximately 21
- long pass filter 230 has a minimum transmission exceeding 90% for wavelengths greater than approximately 360 nm, and a maximum transmission of 0.05% for wavelengths less than approximately 337 nm., and is available from Barr Associates of Westford, MA.
- Spectrograph 235 receives the return fluorescence from filter 230 and spatially separates the spectral components of the return fluorescence for detection by optical detector 240.
- spectrograph 235 and optical detector 240 are available together, sold as a Model 77442 spectrograph 235 and an INSTASPEC IV model optical detector 240, each from Oriel Instruments of Stratford, CT.
- optical detector 240 is a 1024 X 256 pixel charge-coupled device (CCD) array detector.
- Optical detector 240 is includes a thermoelectric cooler for maintaining its temperature at approximately 0 degrees Celsius to reduce its dark-current noise.
- Spectrograph 235 provides a return fluorescence light spectrum that ranges from approximately 275 nm to 725 nm for gastrointestinal polyp detection applications. For other applications, other return fluorescence wavelengths will result. This 275-725 nm spectral range is spread across the 1024 pixel dimension of CCD optical detector 240.
- Each of the 1024 discrete wavelengths is detected by 256 CCD detector elements.
- the data from the 256 CCD detector elements at each of the 1024 discrete wavelengths is summed, providing a resulting 1024 data points corresponding to the 1024 discrete wavelengths.
- the resulting 1024 data points obtained in response to a light pulse is referred to as a frame of data.
- a series of light pulses results in a series of data frames that are stored and transferred to a tissue characterization and diagnosis module, as described below.
- spectrograph 235 provides data at wavelengths approximately between 275-725 nm, much of the return fluorescence data for tissue characterization is typically contained within a range of wavelengths that is approximately between 375 nm and 600 nm, as described below. 22
- FIG. 3 A is a block diagram illustrating generally one embodiment of a hardware configuration for performing signal processing and diagnosis for tissue classification.
- the embodiment of Figure 3 A includes computer 300 and I/O interface 305.
- I/O interface 305 is a Model CTM-10 available from Keithley Metrabyte of Cleveland, OH.
- I/O interface 305 receives a user input signal from the operator, such as from footswitch 175, for initiating a tissue diagnosis.
- I/O interface 305 initiates tissue diagnosis based on a user input signal received from any other device such as, for example, based on input received from one or more switches located on proximal end 105 of endoscope 100, or is voice-activated using a microphone and a voice-recognition module.
- the present invention provides low-cost integration with existing endoscopy equipment already in use. This also makes the present invention easy for an endoscopist to use.
- Tissue diagnosis is initiated by computer 300, which sends a trigger signal, such as a TTL square wave trigger signal, to detector card 310 and laser 200 through I/O interface 305.
- Detector card 310 receives, at node 245, the return fluorescence spectral signal from optical detector 240.
- detector card 310 is available together with optical detector 240, as an INSTASPEC IV model from Oriel Instruments of Stratford, CT.
- optical detector 240 serially provides a frame of data having 1024 analog data points, each corresponding to a particular wavelength or range of wavelengths.
- Detector card 310 performs an 8-bit analog-to-digital (A/D) conversion on each of the 1024 analog data points in the frame of data received from optical detector 240.
- A/D analog-to-digital
- detector card 310 In response to each light pulse, detector card 310 provides a resulting 1024 byte output data frame to be stored by computer 300, such as on hard disk drive 315.
- computer 300 is a single board personal computer including a 166 MHz microprocessor sold as a PENTIUM model by Intel Corp. of Santa Clara, CA, and using an operating system sold as WINDOWS 95 by Microsoft Corp. of Redmond, WA.
- Computer 300 includes a diagnosis module, implemented as a sequence of instructions on the microprocessor, for processing 23 the digitized data received from detector card 310 to provide a tissue characterization or diagnosis, as described below.
- computer 300 includes a hard disk drive 315, such as a 2 gigabyte (GB) EIDE hard disk drive.
- Computer 300 also optionally includes a removable disk, such as floppy disk drive 320, for storing tissue data files and diagnosis information.
- Display driver 330 provides an indicator of the tissue diagnosis and/or an instantaneous or average intensity vs. wavelength graph of the return fluorescence spectra to display 160.
- the present invention includes a video interface 335 for providing an indicator of the tissue diagnosis to a commercially available endoscope monitor 185, either directly or through a commercially available endoscope computer 340.
- endoscope 100 and accompanying camera 180, endoscope computer 340, and endoscope monitor 185 are existing equipment already available.
- An endoscopist typically views, on endoscope monitor 185, a visual image of the tissue 130 at the distal end 110 of the endoscope 100.
- Video interface 335 of the present invention advantageously provides an indicator of the tissue diagnosis to the same endoscope monitor 185 together with the visual image of the tissue 130 obtained from camera 180.
- video interface 335 includes a CORONA model video overlay board available from Matrox of Quebec,
- the present invention provides low-cost integration with existing endoscopy equipment already in use. This also makes the present invention easy for an endoscopist to use, and easy to integrate into the existing medical routine procedures.
- Hardware Example Including Image Enhancement Figure 3B is a block diagram illustrating generally another embodiment of a hardware configuration that includes an image enhancement module 350.
- Image enhancement module 350 performs real time color and/or contrast enhancement or other image enhancement signal processing of the endoscopic video image of the tissue 130.
- the image enhancement sharpens the endoscopic video image, enhances image depth, and compensates for uneven lighting. This 24 assists the physician in locating abnormal or suspect tissue 130 sites for characterization, classification, or diagnosis using the optical biopsy techniques disclosed herein.
- image enhancement module 350 includes a Model CCE-3000 enhancement board from Digivision, Inc. of San Diego, CA, which receives a video image of tissue 130 from endoscope camera 180 or endoscope computer 340. Image enhancement module 350 performs the above-described image enhancement operations, providing a resulting signal to video interface 335.
- video interface 335 includes a real-time color lookup table for identifying and remapping particular colors in the enhanced video image. The identified colors in the video image are highlighted for the physician by video interface 335, such as by remapping the identified colors to more easily discernable colors using the look-up table of video interface 335. In this way, for example, colors that are characteristic of tissue abnormalities are recognized and highlighted for the physician. This allows the physician to easily locate such tissue sites for performing an optical biopsy using the techniques disclosed herein.
- Example Figure 4 is a flow chart illustrating generally an overview of one embodiment of using the present invention for characterizing or diagnosing tissue. As illustrated in Figure 4, using the present invention includes performing startup procedures 400, background calibration procedures 405, tissue data acquisition 410, and tissue diagnosis 415, each of which are described in more detail below. Startup Procedures
- FIG. 5 is a flow chart illustrating generally one embodiment of steps included in performing startup procedures 400, such as when console 155 is powered on or otherwise prepared for a patient procedure.
- Startup procedures 400 are performed before connecting diagnostic optical fiber 135.
- diode alignment of optical detector 240 is checked. This includes acquiring data from a reference material having known fluorescence characteristics.
- a suitable reference material is barium oxide. Other reference materials may also be used during startup procedures 400.
- the reference 25 material is positioned at optical coupler 220, located on console 155, at which diagnostic optical fiber 135 is later connected.
- a sequence of light pulses is delivered from laser 200. Resulting return light from the reference material is transmitted to and detected by optical detector 240.
- Optical detector 240 and detector card 310 provide a resulting series of frames of data to computer 300, each frame of data including 1024 data bytes. Each data byte corresponds to a particular wavelength of detected return light that is obtained from one of the 1024 sets of diodes across which the return light spectra is spread.
- laser 200 delivers one light pulse for every other detection by optical detector 240.
- optical detector 240 performs two detections corresponding to each light pulse delivered from laser 200. A first detection corresponds to the return fluorescence in response to the light pulse. A second detection corresponds to return light detected in the absence of a light pulse delivered from laser 200 (e.g., between responses to light pulses from laser 200).
- the second detection provides a "dark current" measurement of the response of optical detector 240 even in the absence of light pulses from laser 200.
- computer 300 uses the data obtained in response to light pulses from laser 200, computer 300 checks the peak intensity wavelength obtained from the set of diodes in optical detector 240.
- the peak intensity should be obtained from a set of diodes that is within +/- 2 diode sets of a value obtained for the same reference material and earlier stored in a configuration file on computer 300.
- the detector signal of optical detector 240 is checked. This includes checking the signal intensity of the return light obtained in the absence of light pulses of the reference material is checked. This also includes ensuring that the peak "dark current” return light intensity is less than a maximum value that was earlier stored in the configuration file. This further includes ensuring that a "dark current" coefficient of variation, over a series of frames of dark current data, is less than a maximum value that was earlier stored in the configuration file.
- the temperature of optical detector 240 is checked to ensure that it is within a range specified in the configuration file. As described above, cooling optical detector 240 reduces its dark current noise.
- Background Calibration Procedures After startup procedures 400, diagnostic optical fiber 135 is connected to optical coupler 220 on console 155. Background calibration procedures 405 include performing a background reading to obtain a measurement of system properties. These system properties include the properties of the particular diagnostic optical fiber 135. By obtaining the background reading, a subsequent background correction can be applied to subsequent measurements characterizing tissue 130, so that the effect of these system properties can be eliminated. The background reading is performed with the distal end of diagnostic optical fiber 135 in a dark environment to provide shielding from room fluorescent lights or other light.
- laser 200 provides a series of light pulses.
- Optical detector 240 detects a background return light data frame in response to each of the light pulses.
- optical detector 240 also provides dark current data frames from corresponding detections obtained between light pulses from laser 200.
- Each background return light data frame is checked to ensure that its variance does not exceed a maximum value from a data frame stored in the configuration file.
- the background return light data frames are averaged to provide an average background data frame that is indicative of the system properties.
- subsequent tissue characterization measurements are corrected by subtracting the average background data frame, as described below.
- background calibration procedures 405 include performing a background reading with the distal end of diagnostic optical fiber 135 aimed at a known reference material such as, for example, barium oxide.
- laser 200 provides a series of light pulses to the reference material.
- Optical detector 240 detects a reference return light data frame in response to each of the light pulses.
- optical detector 240 also provides dark current data frames from corresponding detections obtained between light pulses from laser 200.
- Each reference return light data frame is checked to ensure that its variance does not exceed a maximum value from a data frame stored in the configuration file.
- the reference return light data frames are averaged to provide an average reference data frame that is indicative of the system properties.
- subsequent tissue characterization measurements are normalized using the average reference data frame, as described below.
- the temperature of optical detector 240 is checked to ensure that it is within an acceptable range specified in the configuration file. Then, laser 200 provides a series of light pulses to tissue 130. Optical detector 240 detects a return fluorescence data frame from tissue 130 in response to each of the light pulses. In one embodiment, optical detector 240 also provides dark current data frames from corresponding detections obtained between light pulses from laser 200. The acquired data frames are stored on hard disk drive 315 by computer 300 for subsequent tissue characterization and diagnosis.
- FIG. 6 is a flow chart illustrating generally one embodiment of techniques for tissue diagnosis at step 415.
- tissue diagnosis includes correcting the tissue characterization data frames at step 600 before performing further data processing.
- correction of the tissue characterization data frames includes subtracting the background reading provided by the average background data frame, as illustrated in Equation 1. 28
- T ON is a return fluorescence data frame in response to an incident light pulse from laser 200 onto tissue 130
- B ON is a return light frame in response to an incident light pulse from laser 200 into a dark environment in the absence of tissue 130
- K cal is a calibration frame that adjusts for the individual response of each diode in optical detector 240 based on Plank's blackbody curve.
- T ON corrected is a resulting corrected return fluorescence data frame obtained in response to an incident light pulse from laser 200 onto tissue 130.
- the technique illustrated in Equation 1 corrects for the system properties, including the properties of the diagnostic optical fiber 135, as described above. It does not, however, correct for the effect of endoscope light (i.e., white light provided at the distal end 110 of endoscope 100 to provide the endoscopist with a visual image of tissue 130 through viewing optics 115.
- tissue characterization data frames are corrected at step 600 for both system properties and endoscope light, such as illustrated in Equation 2.
- T 0N is a return fluorescence data frame in response to an incident light pulse from laser 200 onto tissue 130
- T 0FF is a dark current data frame from tissue 130
- B 0N is an average return light frame in response to an incident light pulse from laser 200 into a dark environment in the absence of tissue 130
- B 0FF is an average dark current data frame from a dark environment in the absence of tissue 130
- K cal is a calibration frame that adjusts for the individual response of each diode in optical detector 240 based on Plank's blackbody curve.
- T 0N conected is a resulting corrected return fluorescence data frame obtained in response to an incident light pulse from laser 200 onto tissue 29
- Each frame of return fluorescence data includes 1024 data bytes, with each data byte corresponding to a distinct wavelength. For tissue characterization, only those wavelengths containing substantial return fluorescence data are of interest.
- each frame is truncated at step 605 to form a subframe, containing only the particular wavelength range of interest, for further signal processing.
- the subframe corresponds to only those wavelengths that are approximately between 375 nm and 600 nm.
- the acquired signal intensity is checked. This includes checking the corrected peak intensity of each subframe to ensure that it exceeds a minimum value stored in the configuration file.
- the signal variation is checked. This includes forming a set of coefficients. Each coefficient corresponds to a particular wavelength in the wavelength range, and is formed from the corresponding data byte in each subframe of the series of data subframes. A comparison with corresponding values stored in the configuration file ensure that each coefficient does not exceed a maximum value for that particular wavelength of light.
- each subframe is individually normalized.
- the data bytes in each subframe are summed.
- Each data byte is then divided by the sum of the data bytes for its subframe.
- each data bytes in each subframe is divided by the sum of the data bytes in the average reference data frame (obtained from a reference material such as, for example, barium oxide, as described above).
- each data byte in each subframe is divided by the maximum intensity data bytes of the average reference data frame obtained from the reference material.
- a set of average intensities is formed.
- Each average intensity corresponds to a particular wavelength of light in the wavelength range, and is formed from the corresponding normalized data byte in each normalized subframe of the sequence of data.
- a single average intensity subframe is formed from the series of subframes of data.
- the data is analyzed.
- the data analysis includes using the average intensities, obtained at step 625, at particular wavelengths in the average intensity subframe.
- One embodiment of such data analysis is illustrated by way of example, but not by way of limitation, in Equation 3.
- 1 390 , 1 42S , I m , I 500 , I 525 are the normalized average intensities obtained at step 625 at wavelengths of 390 nm, 425 nm, 460 nm, 500 nm, and 525 nm, respectively.
- the constants C, B j , B 2 , B 3 , B 4 , B 5 are coefficients that are obtained, in one embodiment, from logistics regression analysis on other tissue samples and stored in the configuration file.
- S is the score obtained when Equation 3 is applied to intensity data from a particular tissue sample.
- E quation 3 describes the use of particu ar wavelengths for tissue characterization
- the invention also includes the use of different wavelengths, or a different number of wavelengths (i.e., using either fewer wavelengths, or using more wavelengths).
- the invention also includes the use of intensities near those particular wavelengths. For example, I m could alternatively be formed by averaging the intensity values of several different wavelengths centered around 31
- I 425 could alternatively be formed by averaging the intensity values of several different wavelengths centered around 425 nm, etc.
- the score, S, from Equation 3 is used to obtain a probability factor, such as illustrated in Equation 4.
- Equation 4 e is the exponential function, S is the score obtained when
- Equation 3 is applied to intensity data from a particular tissue sample, and P is a resulting probability factor that is used at step 635 to characterize the tissue as being normal, hyperplastic, adenomatous, or malignant.
- P is a resulting probability factor that is used at step 635 to characterize the tissue as being normal, hyperplastic, adenomatous, or malignant.
- P is greater than or equal to a threshold value in the configuration file, the tissue is characterized as being adenomatous or malignant.
- This diagnosis indicates that treatment (e.g., taking a physical tissue biopsy sample or mechanically removing at least a portion of the tissue) should be performed.
- An audible or visual indicator of the result of the diagnosis is displayed at step 640, such as on display 160 or on endoscope monitor 185.
- P is less than the threshold value, the tissue is instead classified as being normal or hyperplastic.
- Such a diagnosis indicates that treatment (e.g., taking a physical tissue biopsy sample or mechanically removing at least a portion of the tissue) should not be performed.
- An indicator of this diagnosis is also displayed at step 640 to the operator, as described above.
- Other threshold values of P are used to further classify the tissue, such as to distinguish between adenomatous and malignant tissue, or to distinguish between normal and hyperplastic tissue.
- the displayed indicator clearly indicates whether the physician should treat the tissue site, without any need for further subjective evaluation of the nature of the tissue site by the physician.
- a binary (i.e., two-state) audible or visual indicator such as an icon, is displayed.
- the binary indicator indicates whether to (1) “treat” or “biopsy,” or, alternatively, (2) "not treat” or “not biopsy”.
- a physician performs a physical biopsy sample on the characterized tissue 130 using the forceps 140 if treatment is indicated by the displayed indicator.
- the physician does not 32 perform a physical biopsy sample on the characterized tissue 130 if no treatment is indicated by the displayed indicator.
- FIG. 7 is a flow chart illustrating generally an alternative embodiment of techniques for tissue diagnosis at step 415.
- each wavelength in a subframe is averaged with the corresponding wavelengths in the other subframes, before normalization, to form a single average intensity subframe.
- the average intensity subframe is then normalized by summing the data bytes in the average intensity subframe.
- Each data byte in the average intensity subframe is then divided by the sum of the data bytes for the average intensity subframe to provide a normalized average intensity subframe.
- normalization at step 705 is omitted, and data analysis at step 630 is performed, as described above, on the unnormalized average intensity subframe.
- normalization at step 620 of Figure 6 could also optionally be omitted.
- the tissue diagnosis at step 415 uses the return fluorescence data to compute a probability that is compared to one or more previously stored threshold values to classify the tissue.
- the prestored threshold values used for such diagnosis comparisons are determined clinically by analyzing return fluorescence data from several histopathologically classified samples of normal, hyperplastic, adenomatous, or malignant tissue, such as by logistics regression analysis, multivariate linear regression analysis (MVLR), stepwise regression analysis, best subset analysis, spectral peak(s) ratio analysis, neural network analysis, or any other suitable data analysis technique. These data analysis techniques are also used to compute coefficient values, such as illustrated in Equation 3 and Table 1.
- MVLR multivariate linear regression
- Equation 5 Another example of analysis of the return fluorescence data at step 630 is illustrated generally in Equation 5.
- I m , I 425 , 1 460 , 1 525 are normalized average intensities obtained at step 625 at wavelengths of 390 nm, 425 nm, 460 nm, and 525 nm, respectively. These wavelengths correspond to fluorescence variables resulting from particular components of the tissue, i.e., collagen, hemoglobin r-absorption, NADH, and FAD, respectively.
- the constants C, R ; , B 2 , B 3 , B 4 are coefficients obtained from the configuration file, one example of which is illustrated in Table 2. These coefficients are derived, for example, by the MVLR techniques carried out on other tissue samples, as described above.
- S is the score obtained when Equation 5 is applied to intensity data from a particular tissue sample.
- S is used at step 635, in comparison to one or more threshold values stored in the configuration file, to characterize the tissue as being normal, hyperplastic, adenomatous, or malignant.
- threshold values are derived, for example, by the MVLR techniques carried out on other tissue samples, as described above.
- Equation 6 Another example of analysis of the return fluorescence data at step 630 is illustrated generally in Equation 6.
- I 350 , 1 365 , 1 380 , 1 454 , 1 483 , 1 543 , 1 676 , and l 691 are normalized average intensities obtained at step 625 at wavelengths of 350 nm, 385 nm, 380 nm, 454 nm, 483 nm, 543 nm, 676 nm, and 691 nm respectively.
- the constants C, B abuse B 2 , B 3 , B 4 , B 5 , B 6 , B 7 , and B 8 are coefficients obtained from the configuration file, one example of which is illustrated in Table 3. These coefficients are derived, for example, by the stepwise regression techniques carried out on other tissue samples, as described above.
- S is the score obtained when Equation 6 is applied to intensity data from a particular tissue sample.
- S is used at step 635, in comparison to one or more threshold values stored in the configuration file, to characterize the tissue (e.g., as being normal, hyperplastic, adenomatous, or malignant), such as described above.
- threshold values are derived, for example, by stepwise regression techniques carried out on other tissue samples, as described above.
- FIG. 8 is a graph illustrating generally intensity vs. wavelength for wavelengths between 300 nm and 600 nm from colonic tissue 130 that is normal, as illustrated by curve 800, hyperplastic, as illustrated by curve 805, and adenomatous, as illustrated by curve 810.
- Figure 8 35 also illustrates, by way of example, the particular sample wavelengths (e.g., 390 nm, 425 nm, 460 nm, 500 nm, and 525 nm) used in the example of Equation 3.
- One curve-shape evaluation technique includes evaluating the slope of the intensity vs.
- wavelength curve at various sample wavelengths such as those illustrated in Equation 3 and Figure 8.
- a difference is taken between the intensities at 390 nm and a substantially adjacent wavelength to provide an indication of the slope of the intensity vs. wavelength curve at that particular wavelength.
- multiple differences at approximately adjacent wavelengths is taken and averaged to provide an indication of slope.
- Similar slope information is obtained at other wavelengths, such as 425 nm, 460 nm, 500 nm, and 525 nm.
- the slope information is used, either alone, or in combination with intensity (magnitude) information, to characterize the tissue.
- this slope information is used to provide tissue characterization and diagnosis in place of the other data analysis techniques of step 630.
- the slope information provides an adjunctive diagnosis in addition to the data analysis technique of step 630.
- curve-shaping evaluation also includes similarly evaluating curvature of the intensity vs. wavelength data, or any other suitable curve-shape evaluation technique. Another example of analysis of the return fluorescence data at step 630 is illustrated generally in Equation 7.
- Equation 7 S 4354 and S 4674 are slopes of the intensity vs. wavelength curve centered around example wavelengths of approximately 435.4 nm and 467.4 nm, respectively, and ; and C 2 are coefficients stored in the configuration file, one example of which is illustrated in Table 4. These coefficients are derived, for example, by the best subset analysis techniques carried out on other tissue samples, as described above. Nis score obtained when Equation 7 is applied to intensity data obtained from a particular tissue sample. X is used at step 635, in comparison to one or more threshold values stored in the configuration file, to characterize the tissue as being normal, hyperplastic, 36 adenomatous, or malignant, such as described above. Such threshold values are derived, for example, by best subset analysis carried out on other tissue samples, as described above.
- slopes S 4354 and S 4674 many different techniques can be used to form slopes S 4354 and S 4674 .
- One embodiment uses normalized intensities from 11 adjacent diodes in optical detector 240, the 11 adjacent diodes centered around a center wavelength (e.g., 435.4 nm). Differences are extracted from the intensities obtained from diodes at adjacent detected wavelengths. The resulting differences are averaged to obtain an average slope at the center wavelength (e.g., at 435.4 nm).
- Equation 8 Another example of analysis of the return fluorescence data at step 630 is illustrated generally in Equation 8, which includes analysis of both slope and intensity data for characterizing tissue.
- Equation 8 S 3833 and S 4686 are slopes of the intensity vs. wavelength curve centered around example wavelengths of approximately 383.3 nm and 468.6 nm, respectively, I 4093 is an intensity value at a wavelength of approximately 409.3 nm, and C Constant C 2 , and C 3 are coefficients stored in the configuration file, one example of which is illustrated in Table 5. These coefficients are derived, for example, by best subset analysis techniques carried out on other tissue samples, as described above. Nis the score obtained Equation 8 is applied to intensities obtained from a particular tissue sample.
- X is used at step 635, in comparison to one or more threshold values stored in the configuration file, to characterize the tissue as being normal, hyperplastic, adenomatous, or malignant, such as described above.
- threshold values are 37 derived, for example, by best subset analysis techniques carried out on other tissue samples, as described above.
- Figure 9 is a flow chart illustrating generally, by way of example, but not by way of limitation, one method of diagnosing patients with lower gastrointestinal (e.g., colonic) symptoms.
- a physician performs a first preliminary screening, the results of which may indicate a need for further investigation.
- a digital rectal exam in which the physician feels the interior of the patient's lower colon, may indicate that polyps or other tissue abnormalities are present.
- a patient may have a positive hemocult (i.e., blood in the patient's stools), which also indicates the possibility of tissue abnormalities.
- Other indicators for further investigation include a family history of colonic neoplasm, or even the age of the patient (e.g., greater than 40 years) may indicate that further investigation is warranted.
- a second preliminary screening is performed.
- such procedures might include a subjective visual inspection of the interior of the colon using proctosigmoidoscopy or flexible sigmoidoscopy devices.
- such procedures might include introducing a barium enema into the patient's lower colon and a subsequent subjective radiological evaluation for tissue abnormalities.
- an entire-length colonoscopy is performed, and the large polyps are removed.
- a polypectomy may involve removing the large polyps using a forceps, needle, snare or other mechanical device operating as an endoscopic accessory.
- 38 electrosurgical techniques are used to fulgurate the polyps.
- the entire-length colonoscopy includes a complete examination of the colon for the presence of synchronously occurring polyps in the proximal colon.
- an optical biopsy is performed to characterize the tissue 130 according to the above-described techniques (e.g., see Figures 4-7) of the present invention.
- Individual tissue 130 sites are illuminated and characterized as either normal, hyperplastic, adenomatous, or malignant. If the tissue 130 sites are either adenomatous or malignant, full colonoscopy is performed, as described above, at step 910. If the tissue 130 sites are either normal or hyperplastic, no colonoscopy is indicated.
- a physical biopsy sample is taken and histopathologically analyzed if the optical biopsy indicates adenomatous or malignant tissue 130, and then colonoscopy is performed at step 910.
- the physical biopsy and histopathological analysis is optional and is not essential to practice other aspects of the present invention.
- Tissue characterization eliminates the need for a subjective visual evaluation of the tissue by the physician. It is histopathologically estimated that between 50% and 60% of small (less than 5 mm in diameter) polyps are adenomatous. Recently endoscopic studies, however, indicate that it is difficult or virtually impossible to subjectively visually differentiate between small hyperplastic and adenomatous polyps.
- the present invention provides virtually real-time tissue diagnosis, accurate characterization is possible even if many polyps or other tissue abnormalities are present.
- the optical biopsy at step 915 can also be performed earlier in the patient flow chart of Figure 9, such as during the flexible sigmoidoscopy of step 905.
- a physical biopsy sample could also be taken at step 905 based on the above-described optical biopsy characterization of the tissue.
- the optical biopsy of the present invention is also useful during follow- up procedures to the colonoscopy and polyp removal of step 910. During the follow-up, tissue characterization by optical biopsy indicates whether the polyp resection was complete. 39
- tissue characterization and treatment described above applies not only to polyp diagnosis and removal of physical biopsy samples, but also applies to characterization of smaller malignancies located in surrounding tissue, and characterization of healthy perimeter tissue surrounding abnormal tissue sites. Particular aspects of the invention are described above with respect to light-induced fluorescence.
- aspects of the invention are also capable of use with other tissue characterization techniques including, but not limited to: optical coherent tomography, interference and attenuation across a spectrum (interferometry), optical-acoustic and/or acoustic-optical imaging, fluorescence imaging, photomigration techniques, time-resolved fluorescence spectroscopy, frequency-domain fluorescence spectroscopy, reflection/absorption spectroscopy (elastic scattering), Rayleigh scattering, Raman scattering, and other linear or nonlinear optical techniques.
- tissue diagnosis is on spectroscopic analysis of return fluorescence intensities in combination with one of the above-listed other tissue characterization techniques.
- Extrinsic fluorescence-enhancing agents for enhancing a fluorescence image of the tissue, are not required to practice the present invention, however, the present invention is capable of use with such contrast agents. Moreover, aspects of the invention are also capable of use with other extrinsic agents, such as genetic markers, for the detection of cancer and other tissue abnormalities.
- aspects of the present invention have been described with respect to a single optical fiber for diagnosing the tissue, allowing easy integration with a tissue treatment device. However, aspects of the present invention are also capable of use with multiple fibers for transmitting or collecting electromagnetic energy for diagnosing the tissue. 40
- the techniques disclosed are not limited to tissue characterization and treatment, but could also be applied to characterizing other substances using minimally invasive laparoscopic or general surgical guidance techniques to avoid the complications of damage to surrounding healthy structures.
- the above-described system could also be used to differentiate between oxygenated and deoxygenated hemoglobin, such as for in situ differentiation between arteries and veins using minimally invasive techniques.
- Many other embodiments will be apparent to those of skill in the art upon reviewing the above description.
- the present invention provides, among other things, systems, devices and methods for using native fluorescence to characterize tissue without requiring fluorescence-enhancing agents.
- Image enhancement capability allows easy location of tissue sites to be diagnosed.
- the system allows the use of a single diagnostic optical fiber that is coaxially integrated with a treatment apparatus. Immediate diagnosis allows immediate treatment, such as by using the integrated diagnostic and treatment apparatus. As a result, treatment does not require removing a diagnostic apparatus, and trying to relocate the tissue site using a treatment apparatus.
- the present invention also allows easy integration with existing endoscopy equipment, including endoscopes and/or laparoscopes, endoscope monitors, and endoscope computers.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69939818T DE69939818D1 (en) | 1998-03-09 | 1999-03-09 | OPTICAL BIOPSY SYSTEM FOR TISSUE DIAGNOSTICS |
JP2000535257A JP4477230B2 (en) | 1998-03-09 | 1999-03-09 | Optical student examination apparatus and tissue diagnosis method |
CA002322768A CA2322768C (en) | 1998-03-09 | 1999-03-09 | Optical biopsy system and methods for tissue diagnosis |
EP99913840A EP1065970B1 (en) | 1998-03-09 | 1999-03-09 | Optical biopsy system for tissue diagnosis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/037,722 US6174291B1 (en) | 1998-03-09 | 1998-03-09 | Optical biopsy system and methods for tissue diagnosis |
US09/037,722 | 1998-03-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999045838A1 true WO1999045838A1 (en) | 1999-09-16 |
Family
ID=21895938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/005134 WO1999045838A1 (en) | 1998-03-09 | 1999-03-09 | Optical biopsy system and methods for tissue diagnosis |
Country Status (7)
Country | Link |
---|---|
US (1) | US6174291B1 (en) |
EP (2) | EP1065970B1 (en) |
JP (2) | JP4477230B2 (en) |
AT (2) | ATE412363T1 (en) |
CA (1) | CA2322768C (en) |
DE (2) | DE69939818D1 (en) |
WO (1) | WO1999045838A1 (en) |
Cited By (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1089067A2 (en) * | 1999-09-29 | 2001-04-04 | Fuji Photo Film Co., Ltd. | Method of and apparatus for obtaining fluorescence image |
WO2002048692A1 (en) * | 2000-12-13 | 2002-06-20 | Medical Research Council | Apparatus and method for imaging a histological sample |
EP1229836A1 (en) * | 1999-11-05 | 2002-08-14 | SPECTRX, Inc. | Multi-modal optical tissue diagnostic system |
EP1670348A1 (en) * | 2003-09-16 | 2006-06-21 | Perceptronix Medical Inc. | Automated endoscopy device, diagnostic method and uses |
WO2007047033A2 (en) * | 2005-10-18 | 2007-04-26 | Boston Scientific Scimed, Inc. | Method of using an imaging catheter to conduct photodynamic procedures |
WO2008011056A2 (en) * | 2006-07-18 | 2008-01-24 | Trustees Of Boston University, Et Al. | Device with integrated multi-fiber optical probe and methods of use |
CN104000530A (en) * | 2014-06-06 | 2014-08-27 | 李香秀 | Temporary hand-washing device |
US9069130B2 (en) | 2010-05-03 | 2015-06-30 | The General Hospital Corporation | Apparatus, method and system for generating optical radiation from biological gain media |
US9186066B2 (en) | 2006-02-01 | 2015-11-17 | The General Hospital Corporation | Apparatus for applying a plurality of electro-magnetic radiations to a sample |
US9408539B2 (en) | 2010-03-05 | 2016-08-09 | The General Hospital Corporation | Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution |
US9415550B2 (en) | 2012-08-22 | 2016-08-16 | The General Hospital Corporation | System, method, and computer-accessible medium for fabrication miniature endoscope using soft lithography |
US9510758B2 (en) | 2010-10-27 | 2016-12-06 | The General Hospital Corporation | Apparatus, systems and methods for measuring blood pressure within at least one vessel |
US9516997B2 (en) | 2006-01-19 | 2016-12-13 | The General Hospital Corporation | Spectrally-encoded endoscopy techniques, apparatus and methods |
US9557154B2 (en) | 2010-05-25 | 2017-01-31 | The General Hospital Corporation | Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions |
US9615748B2 (en) | 2009-01-20 | 2017-04-11 | The General Hospital Corporation | Endoscopic biopsy apparatus, system and method |
US9629528B2 (en) | 2012-03-30 | 2017-04-25 | The General Hospital Corporation | Imaging system, method and distal attachment for multidirectional field of view endoscopy |
USRE46412E1 (en) | 2006-02-24 | 2017-05-23 | The General Hospital Corporation | Methods and systems for performing angle-resolved Fourier-domain optical coherence tomography |
US9733460B2 (en) | 2014-01-08 | 2017-08-15 | The General Hospital Corporation | Method and apparatus for microscopic imaging |
US9763623B2 (en) | 2004-08-24 | 2017-09-19 | The General Hospital Corporation | Method and apparatus for imaging of vessel segments |
US9784681B2 (en) | 2013-05-13 | 2017-10-10 | The General Hospital Corporation | System and method for efficient detection of the phase and amplitude of a periodic modulation associated with self-interfering fluorescence |
US9795301B2 (en) | 2010-05-25 | 2017-10-24 | The General Hospital Corporation | Apparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images |
US9968261B2 (en) | 2013-01-28 | 2018-05-15 | The General Hospital Corporation | Apparatus and method for providing diffuse spectroscopy co-registered with optical frequency domain imaging |
US9968245B2 (en) | 2006-10-19 | 2018-05-15 | The General Hospital Corporation | Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s) |
US10058250B2 (en) | 2013-07-26 | 2018-08-28 | The General Hospital Corporation | System, apparatus and method for utilizing optical dispersion for fourier-domain optical coherence tomography |
US10117576B2 (en) | 2013-07-19 | 2018-11-06 | The General Hospital Corporation | System, method and computer accessible medium for determining eye motion by imaging retina and providing feedback for acquisition of signals from the retina |
US10228556B2 (en) | 2014-04-04 | 2019-03-12 | The General Hospital Corporation | Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s) |
US10285568B2 (en) | 2010-06-03 | 2019-05-14 | The General Hospital Corporation | Apparatus and method for devices for imaging structures in or at one or more luminal organs |
US10426548B2 (en) | 2006-02-01 | 2019-10-01 | The General Hosppital Corporation | Methods and systems for providing electromagnetic radiation to at least one portion of a sample using conformal laser therapy procedures |
US10478072B2 (en) | 2013-03-15 | 2019-11-19 | The General Hospital Corporation | Methods and system for characterizing an object |
AU2019226243B2 (en) * | 2013-03-12 | 2020-06-04 | Lawrence Livermore National Security, Llc | Assessment of tissue or lesion depth using temporally resolved light scattering spectroscopy |
WO2020112500A1 (en) * | 2018-11-30 | 2020-06-04 | Verily Life Sciences Llc | Endoscopic systems including a multimode optical fiber and a machine learning classifier for interrogating a portion of a body |
US10736494B2 (en) | 2014-01-31 | 2020-08-11 | The General Hospital Corporation | System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device |
US10835110B2 (en) | 2008-07-14 | 2020-11-17 | The General Hospital Corporation | Apparatus and method for facilitating at least partial overlap of dispersed ration on at least one sample |
US10893806B2 (en) | 2013-01-29 | 2021-01-19 | The General Hospital Corporation | Apparatus, systems and methods for providing information regarding the aortic valve |
US10912462B2 (en) | 2014-07-25 | 2021-02-09 | The General Hospital Corporation | Apparatus, devices and methods for in vivo imaging and diagnosis |
US11179028B2 (en) | 2013-02-01 | 2021-11-23 | The General Hospital Corporation | Objective lens arrangement for confocal endomicroscopy |
US11234600B2 (en) * | 2017-07-13 | 2022-02-01 | The Board Of Regents For Oklahoma State University | System and method for tissue visualization |
US11452433B2 (en) | 2013-07-19 | 2022-09-27 | The General Hospital Corporation | Imaging apparatus and method which utilizes multidirectional field of view endoscopy |
US11490826B2 (en) | 2009-07-14 | 2022-11-08 | The General Hospital Corporation | Apparatus, systems and methods for measuring flow and pressure within a vessel |
US11490797B2 (en) | 2012-05-21 | 2022-11-08 | The General Hospital Corporation | Apparatus, device and method for capsule microscopy |
WO2022246117A1 (en) * | 2021-05-21 | 2022-11-24 | Dermasensor, Inc. | Dynamic calibration of light intensity in a system for non-invasive detection of skin cancer using elastic scattering spectroscopy |
Families Citing this family (257)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7236815B2 (en) * | 1995-03-14 | 2007-06-26 | The Board Of Regents Of The University Of Texas System | Method for probabilistically classifying tissue in vitro and in vivo using fluorescence spectroscopy |
US20080146965A1 (en) * | 2003-08-11 | 2008-06-19 | Salvatore Privitera | Surgical Device for The Collection of Soft Tissue |
IL143258A0 (en) * | 2001-05-20 | 2002-04-21 | Given Imaging Ltd | A method for in vivo imaging of the gastrointestinal tract in unmodified conditions |
JP2001017379A (en) * | 1999-07-09 | 2001-01-23 | Fuji Photo Film Co Ltd | Fluorescent diagnostic device |
US6468203B2 (en) | 2000-04-03 | 2002-10-22 | Neoguide Systems, Inc. | Steerable endoscope and improved method of insertion |
US8517923B2 (en) * | 2000-04-03 | 2013-08-27 | Intuitive Surgical Operations, Inc. | Apparatus and methods for facilitating treatment of tissue via improved delivery of energy based and non-energy based modalities |
US8888688B2 (en) | 2000-04-03 | 2014-11-18 | Intuitive Surgical Operations, Inc. | Connector device for a controllable instrument |
US6984203B2 (en) * | 2000-04-03 | 2006-01-10 | Neoguide Systems, Inc. | Endoscope with adjacently positioned guiding apparatus |
US20050085693A1 (en) * | 2000-04-03 | 2005-04-21 | Amir Belson | Activated polymer articulated instruments and methods of insertion |
US6858005B2 (en) * | 2000-04-03 | 2005-02-22 | Neo Guide Systems, Inc. | Tendon-driven endoscope and methods of insertion |
US6610007B2 (en) * | 2000-04-03 | 2003-08-26 | Neoguide Systems, Inc. | Steerable segmented endoscope and method of insertion |
US6678398B2 (en) * | 2000-09-18 | 2004-01-13 | Sti Medical Systems, Inc. | Dual mode real-time screening and rapid full-area, selective-spectral, remote imaging and analysis device and process |
AU2002230842A1 (en) * | 2000-10-30 | 2002-05-15 | The General Hospital Corporation | Optical methods and systems for tissue analysis |
US9295391B1 (en) | 2000-11-10 | 2016-03-29 | The General Hospital Corporation | Spectrally encoded miniature endoscopic imaging probe |
JP3961765B2 (en) * | 2000-12-28 | 2007-08-22 | ペンタックス株式会社 | Electronic endoscope system |
EP2333523B1 (en) | 2001-04-30 | 2020-04-08 | The General Hospital Corporation | Method and apparatus for improving image clarity and sensitivity in optical coherence tomography using dynamic feedback to control focal properties and coherence gating |
AT503309B1 (en) | 2001-05-01 | 2011-08-15 | Gen Hospital Corp | DEVICE FOR DETERMINING ATHEROSCLEROTIC BEARING BY MEASURING OPTICAL TISSUE PROPERTIES |
US6814739B2 (en) | 2001-05-18 | 2004-11-09 | U.S. Endoscopy Group, Inc. | Retrieval device |
US6796710B2 (en) * | 2001-06-08 | 2004-09-28 | Ethicon Endo-Surgery, Inc. | System and method of measuring and controlling temperature of optical fiber tip in a laser system |
ATE404114T1 (en) * | 2001-06-18 | 2008-08-15 | Given Imaging Ltd | SWALLOWABLE IN-VIVO CAPSULE WITH A CIRCUIT BOARD HAVING RIGID AND FLEXIBLE SECTIONS |
JP2005514144A (en) | 2002-01-09 | 2005-05-19 | ネオガイド システムズ, インコーポレイテッド | Apparatus and method for spectroscopic examination of the colon |
US8423110B2 (en) * | 2002-01-09 | 2013-04-16 | Boston Scientific Scimed, Inc. | Imaging device and related methods |
CN1764416A (en) | 2002-01-09 | 2006-04-26 | 新引导系统公司 | Apparatus and method for endoscopic colectomy |
US7355716B2 (en) * | 2002-01-24 | 2008-04-08 | The General Hospital Corporation | Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands |
US20030199753A1 (en) * | 2002-04-23 | 2003-10-23 | Ethicon Endo-Surgery | MRI compatible biopsy device with detachable probe |
US7769426B2 (en) * | 2002-04-23 | 2010-08-03 | Ethicon Endo-Surgery, Inc. | Method for using an MRI compatible biopsy device with detachable probe |
US7826883B2 (en) * | 2002-04-23 | 2010-11-02 | Devicor Medical Products, Inc. | Localization mechanism for an MRI compatible biopsy device |
US20110201924A1 (en) * | 2002-04-30 | 2011-08-18 | The General Hospital Corporation | Method and Apparatus for Improving Image Clarity and Sensitivity in Optical Tomography Using Dynamic Feedback to Control Focal Properties and Coherence Gating |
US7662094B2 (en) * | 2002-05-14 | 2010-02-16 | Given Imaging Ltd. | Optical head assembly with dome, and device for use thereof |
WO2004014227A1 (en) * | 2002-08-13 | 2004-02-19 | Given Imaging Ltd. | System for in vivo sampling and analysis |
WO2004028336A2 (en) * | 2002-09-30 | 2004-04-08 | Given Imaging Ltd. | Reduced size imaging device |
AU2003269438A1 (en) * | 2002-09-30 | 2004-04-19 | Given Imaging Ltd. | In-vivo sensing system |
US20040064053A1 (en) * | 2002-09-30 | 2004-04-01 | Chang Sung K. | Diagnostic fluorescence and reflectance |
DE10246521B4 (en) * | 2002-10-05 | 2005-11-10 | Karl Storz Gmbh & Co. Kg | endoscope |
WO2004036803A2 (en) * | 2002-10-15 | 2004-04-29 | Given Imaging Ltd. | Device, system and method for transfer of signals to a moving device |
US7438692B2 (en) * | 2002-10-18 | 2008-10-21 | Mark Tsonton | Localization mechanism for an MRI compatible biopsy device |
US20080045788A1 (en) * | 2002-11-27 | 2008-02-21 | Zvika Gilad | Method and device of imaging with an in vivo imager |
US6980573B2 (en) * | 2002-12-09 | 2005-12-27 | Infraredx, Inc. | Tunable spectroscopic source with power stability and method of operation |
WO2004058041A2 (en) * | 2002-12-26 | 2004-07-15 | Given Imaging Ltd. | Immobilizable in vivo sensing device |
EP1576530A4 (en) * | 2002-12-26 | 2009-03-25 | Given Imaging Ltd | In vivo imaging device and method of manufacture thereof |
US7567349B2 (en) | 2003-03-31 | 2009-07-28 | The General Hospital Corporation | Speckle reduction in optical coherence tomography by path length encoded angular compounding |
JP2006516739A (en) | 2003-01-24 | 2006-07-06 | ザ・ジェネラル・ホスピタル・コーポレイション | System and method for identifying tissue using a low coherence interferometer |
US8054468B2 (en) | 2003-01-24 | 2011-11-08 | The General Hospital Corporation | Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands |
US6912050B2 (en) * | 2003-02-03 | 2005-06-28 | Hach Company | Phase shift measurement for luminescent light |
US8882657B2 (en) | 2003-03-07 | 2014-11-11 | Intuitive Surgical Operations, Inc. | Instrument having radio frequency identification systems and methods for use |
US7102758B2 (en) | 2003-05-06 | 2006-09-05 | Duke University | Fourier domain low-coherence interferometry for light scattering spectroscopy apparatus and method |
KR101546024B1 (en) | 2003-06-06 | 2015-08-20 | 더 제너럴 하스피탈 코포레이션 | Process and apparatus for a wavelength tunning source |
US20040267121A1 (en) * | 2003-06-12 | 2004-12-30 | Sarvazyan Armen P. | Device and method for biopsy guidance using a tactile breast imager |
JP4306380B2 (en) * | 2003-09-10 | 2009-07-29 | 株式会社日立メディコ | Medical image display method and apparatus |
US20080077005A1 (en) * | 2004-08-12 | 2008-03-27 | Piron Cameron A | System and Method for Multimodality Breast Imaging |
US7379769B2 (en) * | 2003-09-30 | 2008-05-27 | Sunnybrook Health Sciences Center | Hybrid imaging method to monitor medical device delivery and patient support for use in the method |
US7908690B2 (en) * | 2003-09-30 | 2011-03-22 | Sentinelle Medical, Inc. | Supine patient support for medical imaging |
US7970452B2 (en) * | 2003-09-30 | 2011-06-28 | Hologic, Inc. | Open architecture imaging apparatus and coil system for magnetic resonance imaging |
KR101384553B1 (en) | 2003-10-27 | 2014-04-11 | 더 제너럴 하스피탈 코포레이션 | Method and apparatus for performing optical imaging using frequency-domain interferometry |
WO2005054780A1 (en) * | 2003-11-28 | 2005-06-16 | The General Hospital Corporation | Method and apparatus for three-dimensional spectrally encoded imaging |
US8326404B2 (en) * | 2003-11-28 | 2012-12-04 | British Columbia Cancer Agency Branch | Multimodal detection of tissue abnormalities based on raman and background fluorescence spectroscopy |
US20050171436A1 (en) * | 2004-01-09 | 2005-08-04 | Clarke Richard H. | Raman spectroscopy for monitoring drug-eluting medical devices |
US7922654B2 (en) | 2004-08-09 | 2011-04-12 | Boston Scientific Scimed, Inc. | Fiber optic imaging catheter |
EP1737335B1 (en) | 2004-03-23 | 2013-05-15 | Boston Scientific Limited | In-vivo visualization system |
US11819192B2 (en) | 2004-03-23 | 2023-11-21 | Boston Scientific Scimed, Inc. | In-vivo visualization system |
US20060155178A1 (en) * | 2004-03-26 | 2006-07-13 | Vadim Backman | Multi-dimensional elastic light scattering |
US20050250091A1 (en) * | 2004-05-05 | 2005-11-10 | Chemlmage Corporation | Raman molecular imaging for detection of bladder cancer |
US7697576B2 (en) * | 2004-05-05 | 2010-04-13 | Chem Image Corporation | Cytological analysis by raman spectroscopic imaging |
US20060281068A1 (en) * | 2005-06-09 | 2006-12-14 | Chemimage Corp. | Cytological methods for detecting a disease condition such as malignancy by Raman spectroscopic imaging |
US7708751B2 (en) * | 2004-05-21 | 2010-05-04 | Ethicon Endo-Surgery, Inc. | MRI biopsy device |
US8932233B2 (en) | 2004-05-21 | 2015-01-13 | Devicor Medical Products, Inc. | MRI biopsy device |
US9638770B2 (en) * | 2004-05-21 | 2017-05-02 | Devicor Medical Products, Inc. | MRI biopsy apparatus incorporating an imageable penetrating portion |
EP1754016B1 (en) | 2004-05-29 | 2016-05-18 | The General Hospital Corporation | Process, system and software arrangement for a chromatic dispersion compensation using reflective layers in optical coherence tomography (oct) imaging |
WO2005122878A1 (en) * | 2004-06-15 | 2005-12-29 | Umc Utrecht Holding B.V. | Method and device for the detection of cancer |
US9968290B2 (en) * | 2004-06-30 | 2018-05-15 | Given Imaging Ltd. | Apparatus and methods for capsule endoscopy of the esophagus |
US7643865B2 (en) * | 2004-06-30 | 2010-01-05 | Given Imaging Ltd. | Autonomous in-vivo device |
US20060015013A1 (en) * | 2004-06-30 | 2006-01-19 | Zvika Gilad | Device and method for in vivo illumination |
US7596403B2 (en) | 2004-06-30 | 2009-09-29 | Given Imaging Ltd. | System and method for determining path lengths through a body lumen |
US7447408B2 (en) | 2004-07-02 | 2008-11-04 | The General Hospital Corproation | Imaging system and related techniques |
KR101332222B1 (en) * | 2004-08-06 | 2013-11-22 | 더 제너럴 하스피탈 코포레이션 | Process, system and software arrangement for determining at least one location in a sample using an optical coherence tomography |
JP5334415B2 (en) * | 2004-08-24 | 2013-11-06 | ザ ジェネラル ホスピタル コーポレイション | Process, system and software for measuring mechanical strain and elastic properties of samples |
US7365859B2 (en) * | 2004-09-10 | 2008-04-29 | The General Hospital Corporation | System and method for optical coherence imaging |
US7366376B2 (en) * | 2004-09-29 | 2008-04-29 | The General Hospital Corporation | System and method for optical coherence imaging |
MX2007003777A (en) * | 2004-09-30 | 2007-05-24 | Zila Biotechnology Inc | Light-directed method for detecting and aiding further evaluation of abnormal mucosal tissue. |
US8357148B2 (en) * | 2004-09-30 | 2013-01-22 | Boston Scientific Scimed, Inc. | Multi-functional endoscopic system for use in electrosurgical applications |
JP5175101B2 (en) * | 2004-10-29 | 2013-04-03 | ザ ジェネラル ホスピタル コーポレイション | System and method for performing Jones matrix based analysis to measure unpolarized polarization parameters using polarization sensitive optical coherence tomography |
AU2005229684A1 (en) * | 2004-11-04 | 2006-05-18 | Given Imaging Ltd | Apparatus and method for receiving device selection and combining |
US7417740B2 (en) * | 2004-11-12 | 2008-08-26 | Medeikon Corporation | Single trace multi-channel low coherence interferometric sensor |
US20060122587A1 (en) * | 2004-11-17 | 2006-06-08 | Shiva Sharareh | Apparatus for real time evaluation of tissue ablation |
US20060229515A1 (en) * | 2004-11-17 | 2006-10-12 | The Regents Of The University Of California | Fiber optic evaluation of tissue modification |
EP2278266A3 (en) | 2004-11-24 | 2011-06-29 | The General Hospital Corporation | Common-Path Interferometer for Endoscopic OCT |
US8922781B2 (en) | 2004-11-29 | 2014-12-30 | The General Hospital Corporation | Arrangements, devices, endoscopes, catheters and methods for performing optical imaging by simultaneously illuminating and detecting multiple points on a sample |
US7854705B2 (en) * | 2004-12-16 | 2010-12-21 | Olga Pawluczyk | Ex vivo verification of biopsy tissue samples |
JP4619803B2 (en) * | 2005-01-26 | 2011-01-26 | 富士フイルム株式会社 | Fluorescence tomographic image acquisition device |
US7688440B2 (en) | 2005-01-27 | 2010-03-30 | Prescient Medical, Inc. | Raman spectroscopic test strip systems |
US7524671B2 (en) * | 2005-01-27 | 2009-04-28 | Prescient Medical, Inc. | Handheld raman blood analyzer |
US7651851B2 (en) * | 2005-01-27 | 2010-01-26 | Prescient Medical, Inc. | Handheld Raman body fluid analyzer |
US20060241385A1 (en) * | 2005-04-12 | 2006-10-26 | Ethicon Endo-Surgery, Inc. | Guided disposable fiducial for breast biopsy localization fixture |
US20060235457A1 (en) * | 2005-04-15 | 2006-10-19 | Amir Belson | Instruments having a rigidizable external working channel |
EP3095379A1 (en) | 2005-04-15 | 2016-11-23 | Surgisense Corporation | Surgical instruments with sensors for detecting tissue properties, and systems using such instruments |
JP2008538612A (en) * | 2005-04-22 | 2008-10-30 | ザ ジェネラル ホスピタル コーポレイション | Configuration, system, and method capable of providing spectral domain polarization sensitive optical coherence tomography |
KR101410867B1 (en) | 2005-04-28 | 2014-06-23 | 더 제너럴 하스피탈 코포레이션 | Systems, processes and software arrangements for evaluating information associated with an anatomical structure by an optical coherence ranging technique |
US8406858B2 (en) | 2005-04-29 | 2013-03-26 | The Regents Of The University Of Colorado, A Body Corporate | Multi-excitation diagnostic system and methods for classification of tissue |
US20070009935A1 (en) * | 2005-05-13 | 2007-01-11 | The General Hospital Corporation | Arrangements, systems and methods capable of providing spectral-domain optical coherence reflectometry for a sensitive detection of chemical and biological sample |
JP2008542758A (en) * | 2005-05-31 | 2008-11-27 | ザ ジェネラル ホスピタル コーポレイション | System, method and apparatus capable of using spectrally encoded heterodyne interferometry for imaging |
US8253936B2 (en) * | 2008-08-08 | 2012-08-28 | Chemimage Corporation | Raman characterization of transplant tissue |
DE602006017558D1 (en) * | 2005-08-09 | 2010-11-25 | Gen Hospital Corp | DEVICE AND METHOD FOR CARRYING OUT POLARIZATION-BASED QUADRATURE DEMODULATION IN OPTICAL COHERENCE TOMOGRAPHY |
WO2007022220A2 (en) * | 2005-08-16 | 2007-02-22 | The General Hospital Corporation | Arrangements and methods for imaging in vessels |
US20070135803A1 (en) * | 2005-09-14 | 2007-06-14 | Amir Belson | Methods and apparatus for performing transluminal and other procedures |
EP1937137B1 (en) | 2005-09-29 | 2022-06-15 | General Hospital Corporation | Method and apparatus for optical imaging via spectral encoding |
US8537366B2 (en) * | 2005-10-11 | 2013-09-17 | Duke University | Systems and methods for endoscopic angle-resolved low coherence interferometry |
CA2626116C (en) * | 2005-10-11 | 2012-08-21 | Duke University | Systems and method for endoscopic angle-resolved low coherence interferometry |
EP1945094B1 (en) * | 2005-10-14 | 2018-09-05 | The General Hospital Corporation | Spectral- and frequency- encoded fluorescence imaging |
EP1948056A2 (en) * | 2005-10-24 | 2008-07-30 | Spectrascience, Inc. | System and method for non-endoscopic optical biopsy detection of diseased tissue |
US9314164B2 (en) | 2005-10-27 | 2016-04-19 | Northwestern University | Method of using the detection of early increase in microvascular blood content to distinguish between adenomatous and hyperplastic polyps |
US20090203977A1 (en) * | 2005-10-27 | 2009-08-13 | Vadim Backman | Method of screening for cancer using parameters obtained by the detection of early increase in microvascular blood content |
US20070161857A1 (en) | 2005-11-22 | 2007-07-12 | Neoguide Systems, Inc. | Method of determining the shape of a bendable instrument |
JP2009517608A (en) * | 2005-11-23 | 2009-04-30 | ネオガイド システムズ, インコーポレイテッド | Non-metallic multi-strand control cable for steerable devices |
US7896805B2 (en) * | 2005-11-23 | 2011-03-01 | Given Imaging Ltd. | In-vivo imaging device and optical system thereof |
WO2007063550A2 (en) * | 2005-12-02 | 2007-06-07 | Given Imaging Ltd. | System and device for in vivo procedures |
US9320417B2 (en) | 2005-12-29 | 2016-04-26 | Given Imaging Ltd. | In-vivo optical imaging device with backscatter blocking |
US20070156051A1 (en) * | 2005-12-29 | 2007-07-05 | Amit Pascal | Device and method for in-vivo illumination |
US20070167834A1 (en) * | 2005-12-29 | 2007-07-19 | Amit Pascal | In-vivo imaging optical device and method |
JP5680826B2 (en) | 2006-01-10 | 2015-03-04 | ザ ジェネラル ホスピタル コーポレイション | Data generation system using endoscopic technology for encoding one or more spectra |
US9087368B2 (en) | 2006-01-19 | 2015-07-21 | The General Hospital Corporation | Methods and systems for optical imaging or epithelial luminal organs by beam scanning thereof |
US20070223006A1 (en) * | 2006-01-19 | 2007-09-27 | The General Hospital Corporation | Systems and methods for performing rapid fluorescence lifetime, excitation and emission spectral measurements |
US20070171433A1 (en) * | 2006-01-20 | 2007-07-26 | The General Hospital Corporation | Systems and processes for providing endogenous molecular imaging with mid-infrared light |
EP1973467B1 (en) * | 2006-01-20 | 2013-10-16 | The General Hospital Corporation | Systems and process for providing speckle reduction using a wave front modulation for optical coherence tomography |
US20070171430A1 (en) * | 2006-01-20 | 2007-07-26 | The General Hospital Corporation | Systems and methods for providing mirror tunnel micropscopy |
JP2009537024A (en) * | 2006-02-01 | 2009-10-22 | ザ ジェネラル ホスピタル コーポレイション | Apparatus for controlling at least one of at least two sites of at least one fiber |
WO2007092911A2 (en) | 2006-02-08 | 2007-08-16 | The General Hospital Corporation | Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy |
US20070208400A1 (en) * | 2006-03-01 | 2007-09-06 | The General Hospital Corporation | System and method for providing cell specific laser therapy of atherosclerotic plaques by targeting light absorbers in macrophages |
WO2007109540A2 (en) * | 2006-03-17 | 2007-09-27 | The General Hospital Corporation | Arrangement, method and computer-accessible medium for identifying characteristics of at least a portion of a blood vessel contained within a tissue using spectral domain low coherence interferometry |
US7742173B2 (en) * | 2006-04-05 | 2010-06-22 | The General Hospital Corporation | Methods, arrangements and systems for polarization-sensitive optical frequency domain imaging of a sample |
WO2007133961A2 (en) | 2006-05-10 | 2007-11-22 | The General Hospital Corporation | Processes, arrangements and systems for providing frequency domain imaging of a sample |
WO2007133964A2 (en) * | 2006-05-12 | 2007-11-22 | The General Hospital Corporation | Processes, arrangements and systems for providing a fiber layer thickness map based on optical coherence tomography images |
WO2007137208A2 (en) | 2006-05-19 | 2007-11-29 | Neoguide Systems, Inc. | Methods and apparatus for displaying three-dimensional orientation of a steerable distal tip of an endoscope |
WO2008011580A2 (en) * | 2006-07-21 | 2008-01-24 | Oncoscope, Inc. | Protective probe tip, particularly for use on a fiber-optic probe used in an endoscopic application |
WO2008016927A2 (en) * | 2006-08-01 | 2008-02-07 | The General Hospital Corporation | Systems and methods for receiving and/or analyzing information associated with electro-magnetic radiation |
FR2904927B1 (en) * | 2006-08-17 | 2018-05-18 | Mauna Kea Technologies | USE OF A FIBER IN VIVO IN SITU CONFOCAL FLUORESCENCE IMAGING SYSTEM, SYSTEM AND METHOD FOR CONFOCAL FIBER IN VIVO IN SITU FLUORESCENCE IMAGING |
EP2054712B1 (en) * | 2006-08-25 | 2015-10-07 | The General Hospital Corporation | Apparatus and methods for enhancing optical coherence tomography imaging using volumetric filtering techniques |
EP2077753B1 (en) * | 2006-09-12 | 2012-12-19 | The General Hospital Corporation | Apparatus, probe and method for providing depth assessment in an anatomical structure |
EP2102583A2 (en) | 2007-01-19 | 2009-09-23 | The General Hospital Corporation | Apparatus and method for controlling ranging depth in optical frequency domain imaging |
US20080206804A1 (en) * | 2007-01-19 | 2008-08-28 | The General Hospital Corporation | Arrangements and methods for multidimensional multiplexed luminescence imaging and diagnosis |
EP2662674A3 (en) * | 2007-01-19 | 2014-06-25 | The General Hospital Corporation | Rotating disk reflection for fast wavelength scanning of dispersed broadbend light |
US8396539B2 (en) * | 2007-02-16 | 2013-03-12 | Medtronic, Inc. | Implantable medical device having optical fiber for sensing electrical activity |
US20080221444A1 (en) * | 2007-03-07 | 2008-09-11 | Ritchie Paul G | Integrated Imaging and Biopsy System with Integrated Surgical, Therapy, and Diagnostic Devices |
WO2008115965A1 (en) * | 2007-03-19 | 2008-09-25 | The General Hospital Corporation | Apparatus and method for providing a noninvasive diagnosis of internal bleeding |
US20080234586A1 (en) * | 2007-03-19 | 2008-09-25 | The General Hospital Corporation | System and method for providing noninvasive diagnosis of compartment syndrome using exemplary laser speckle imaging procedure |
JP2008229024A (en) * | 2007-03-20 | 2008-10-02 | Olympus Corp | Fluorescence observation device |
US9176319B2 (en) * | 2007-03-23 | 2015-11-03 | The General Hospital Corporation | Methods, arrangements and apparatus for utilizing a wavelength-swept laser using angular scanning and dispersion procedures |
US10534129B2 (en) * | 2007-03-30 | 2020-01-14 | The General Hospital Corporation | System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque |
US8045177B2 (en) | 2007-04-17 | 2011-10-25 | The General Hospital Corporation | Apparatus and methods for measuring vibrations using spectrally-encoded endoscopy |
US8115919B2 (en) * | 2007-05-04 | 2012-02-14 | The General Hospital Corporation | Methods, arrangements and systems for obtaining information associated with a sample using optical microscopy |
US9226731B2 (en) * | 2007-05-21 | 2016-01-05 | The Board Of Regents Of The University Of Texas System | Optically guided needle biopsy system using multi-modal spectroscopy in combination with a transrectal ultrasound probe |
US8591521B2 (en) | 2007-06-08 | 2013-11-26 | United States Endoscopy Group, Inc. | Retrieval device |
US20090003666A1 (en) * | 2007-06-27 | 2009-01-01 | Wu Dee H | System and methods for image analysis and treatment |
JP5917803B2 (en) * | 2007-07-31 | 2016-05-18 | ザ ジェネラル ホスピタル コーポレイション | System and method for emitting a beam scanning pattern for fast Doppler optical frequency domain imaging |
US8040608B2 (en) * | 2007-08-31 | 2011-10-18 | The General Hospital Corporation | System and method for self-interference fluorescence microscopy, and computer-accessible medium associated therewith |
CA2699523A1 (en) * | 2007-09-13 | 2009-03-19 | Duke University | Apparatuses, systems, and methods for low-coherence interferometry (lci) |
EP2197546A1 (en) * | 2007-09-14 | 2010-06-23 | Light Sciences Oncology, Inc. | Systems, devices, and methods for photoactive assisted resection |
US20090073439A1 (en) * | 2007-09-15 | 2009-03-19 | The General Hospital Corporation | Apparatus, computer-accessible medium and method for measuring chemical and/or molecular compositions of coronary atherosclerotic plaques in anatomical structures |
US9220398B2 (en) | 2007-10-11 | 2015-12-29 | Intuitive Surgical Operations, Inc. | System for managing Bowden cables in articulating instruments |
WO2009049296A2 (en) * | 2007-10-12 | 2009-04-16 | The General Hospital Corporation | Systems and processes for optical imaging of luminal anatomic structures |
WO2009059034A1 (en) * | 2007-10-30 | 2009-05-07 | The General Hospital Corporation | System and method for cladding mode detection |
EP2207475A4 (en) | 2007-11-05 | 2010-12-22 | Kci Licensing Inc | Identification of tissue for debridement |
WO2009060460A2 (en) * | 2007-11-09 | 2009-05-14 | Given Imaging Ltd. | Apparatus and methods for capsule endoscopy of the esophagus |
US20090124927A1 (en) * | 2007-11-13 | 2009-05-14 | Chest Innovations, Inc. | Endoscopic system for lung biopsy and biopsy method of insufflating gas to collapse a lung |
US7940047B2 (en) | 2007-11-23 | 2011-05-10 | Sentinelle Medical, Inc. | Microcontroller system for identifying RF coils in the bore of a magnetic resonance imaging system |
US20090177094A1 (en) * | 2008-01-08 | 2009-07-09 | Oncoscope, Inc. | Systems and methods for tissue examination, diagnostic, treatment, and/or monitoring |
US20090225324A1 (en) * | 2008-01-17 | 2009-09-10 | The General Hospital Corporation | Apparatus for providing endoscopic high-speed optical coherence tomography |
US8983580B2 (en) * | 2008-01-18 | 2015-03-17 | The Board Of Trustees Of The University Of Illinois | Low-coherence interferometry and optical coherence tomography for image-guided surgical treatment of solid tumors |
US8115934B2 (en) * | 2008-01-18 | 2012-02-14 | The Board Of Trustees Of The University Of Illinois | Device and method for imaging the ear using optical coherence tomography |
US11123047B2 (en) | 2008-01-28 | 2021-09-21 | The General Hospital Corporation | Hybrid systems and methods for multi-modal acquisition of intravascular imaging data and counteracting the effects of signal absorption in blood |
US9332942B2 (en) * | 2008-01-28 | 2016-05-10 | The General Hospital Corporation | Systems, processes and computer-accessible medium for providing hybrid flourescence and optical coherence tomography imaging |
KR101707924B1 (en) | 2008-02-06 | 2017-02-17 | 인튜어티브 서지컬 오퍼레이션즈 인코포레이티드 | A segmented instrument having braking capabilities |
US8182418B2 (en) * | 2008-02-25 | 2012-05-22 | Intuitive Surgical Operations, Inc. | Systems and methods for articulating an elongate body |
WO2009137701A2 (en) | 2008-05-07 | 2009-11-12 | The General Hospital Corporation | System, method and computer-accessible medium for tracking vessel motion during three-dimensional coronary artery microscopy |
US8234078B2 (en) * | 2008-06-05 | 2012-07-31 | The Regents Of The University Of Michigan | Multimodal spectroscopic systems and methods for classifying biological tissue |
US8239139B2 (en) * | 2008-06-05 | 2012-08-07 | The Regents Of The University Of Michigan | Multimodal spectroscopic systems and methods for classifying biological tissue |
US8694266B2 (en) | 2008-06-05 | 2014-04-08 | The Regents Of The University Of Michigan | Multimodal spectroscopic systems and methods for classifying biological tissue |
US8861910B2 (en) * | 2008-06-20 | 2014-10-14 | The General Hospital Corporation | Fused fiber optic coupler arrangement and method for use thereof |
US8416405B2 (en) * | 2008-08-08 | 2013-04-09 | Chemimage Corporation | Raman chemical imaging of implantable drug delivery devices |
US20100081915A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, Alimited Liability Corporation Of The State Of Delaware | Histological facilitation systems and methods |
US20100081916A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware. | Histological facilitation systems and methods |
US20100081926A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Histological facilitation systems and methods |
US20100081924A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Histological facilitation systems and methods |
US20100081928A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Histological Facilitation systems and methods |
US20100081927A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Histological facilitation systems and methods |
US20110190662A1 (en) * | 2008-10-01 | 2011-08-04 | Beacon Endoscopic Corporation | Rapid exchange fna biopsy device with diagnostic and therapeutic capabilities |
US8968210B2 (en) * | 2008-10-01 | 2015-03-03 | Covidien LLP | Device for needle biopsy with integrated needle protection |
US9186128B2 (en) | 2008-10-01 | 2015-11-17 | Covidien Lp | Needle biopsy device |
US9782565B2 (en) | 2008-10-01 | 2017-10-10 | Covidien Lp | Endoscopic ultrasound-guided biliary access system |
US9332973B2 (en) | 2008-10-01 | 2016-05-10 | Covidien Lp | Needle biopsy device with exchangeable needle and integrated needle protection |
US11298113B2 (en) | 2008-10-01 | 2022-04-12 | Covidien Lp | Device for needle biopsy with integrated needle protection |
US7862219B2 (en) * | 2008-10-22 | 2011-01-04 | Advanced Photodynamic Technologies, Inc. | Optical fiber light diffusing device |
US8937724B2 (en) | 2008-12-10 | 2015-01-20 | The General Hospital Corporation | Systems and methods for extending imaging depth range of optical coherence tomography through optical sub-sampling |
EP2382456A4 (en) * | 2009-01-26 | 2012-07-25 | Gen Hospital Corp | System, method and computer-accessible medium for providing wide-field superresolution microscopy |
JP6053284B2 (en) | 2009-02-04 | 2016-12-27 | ザ ジェネラル ホスピタル コーポレイション | Apparatus and method for use of a high speed optical wavelength tuning source |
US9351642B2 (en) | 2009-03-12 | 2016-05-31 | The General Hospital Corporation | Non-contact optical system, computer-accessible medium and method for measurement at least one mechanical property of tissue using coherent speckle technique(s) |
EP2445413B1 (en) * | 2009-06-23 | 2020-02-12 | Invivo Corporation | Variable angle guide holder for a biopsy guide plug |
US8516691B2 (en) | 2009-06-24 | 2013-08-27 | Given Imaging Ltd. | Method of assembly of an in vivo imaging device with a flexible circuit board |
FR2948007B1 (en) * | 2009-07-20 | 2012-06-08 | Chab Lama Al | FIBERED NEEDLE PROBE FOR OPTICAL DIAGNOSIS IN THE DEPTH OF TUMORS. |
JP5856061B2 (en) * | 2009-10-06 | 2016-02-09 | ザ ジェネラル ホスピタル コーポレイション | Apparatus and method for imaging specific cells using spectrally encoded confocal microscopy |
JP5711260B2 (en) * | 2009-12-08 | 2015-04-30 | ザ ジェネラル ホスピタル コーポレイション | Method and apparatus for analyzing, diagnosing and treating treatment of vocal folds by optical coherence tomography |
TWI511702B (en) * | 2009-12-11 | 2015-12-11 | Univ Ishou | Methods for the measurement of endothelial cell dilatation |
JP2013518256A (en) | 2010-01-22 | 2013-05-20 | デユーク・ユニバーシテイ | Multiple windowing scheme for spectroscopic coherence tomography (OCT) and Fourier domain low coherence interferometry |
US9823127B2 (en) | 2010-01-22 | 2017-11-21 | Duke University | Systems and methods for deep spectroscopic imaging of biological samples with use of an interferometer and spectrometer |
US20110201965A1 (en) * | 2010-02-18 | 2011-08-18 | John Anthony Hibner | MRI Compatible Biopsy Device |
US8666673B2 (en) | 2010-05-14 | 2014-03-04 | Biomerieux, Inc | Identification and/or characterization of a microbial agent using taxonomic hierarchical classification |
DE102010017117A1 (en) | 2010-05-27 | 2011-12-01 | Anne Schardey | Surgical instrument |
CN102846304A (en) * | 2010-07-15 | 2013-01-02 | 广州宝胆医疗器械科技有限公司 | Diagnosis and treatment integration confocal colposcopic system |
EP2633796A4 (en) | 2010-10-26 | 2016-12-14 | Konica Minolta Inc | Probe |
US9332926B2 (en) | 2010-11-25 | 2016-05-10 | Invivo Corporation | MRI imaging probe |
WO2012149175A1 (en) | 2011-04-29 | 2012-11-01 | The General Hospital Corporation | Means for determining depth-resolved physical and/or optical properties of scattering media |
WO2012157552A1 (en) | 2011-05-18 | 2012-11-22 | コニカミノルタアドバンストレイヤー株式会社 | Probe |
WO2013013049A1 (en) | 2011-07-19 | 2013-01-24 | The General Hospital Corporation | Systems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography |
JP5834584B2 (en) * | 2011-07-25 | 2015-12-24 | ソニー株式会社 | Information processing apparatus, information processing method, program, and fluorescence spectrum intensity correction method |
EP3835718B1 (en) | 2011-08-25 | 2023-07-26 | The General Hospital Corporation | Apparatus for providing micro-optical coherence tomography inside a respiratory system |
EP2757933B1 (en) | 2011-09-22 | 2019-02-06 | The George Washington University | Systems for visualizing ablated tissue |
WO2013044182A1 (en) | 2011-09-22 | 2013-03-28 | The George Washington University | Systems and methods for visualizing ablated tissue |
WO2013066631A1 (en) | 2011-10-18 | 2013-05-10 | The General Hospital Corporation | Apparatus and methods for producing and/or providing recirculating optical delay(s) |
JP5889398B2 (en) * | 2012-04-05 | 2016-03-22 | Sbiファーマ株式会社 | Sentinel lymph node cancer metastasis identification device |
US9814448B2 (en) | 2012-05-21 | 2017-11-14 | Precision Biopsy, Inc. | Three-dimensional optical imaging and therapy of prostate cancer |
EP2852324A4 (en) | 2012-05-21 | 2016-02-24 | Univ Colorado Regents | Three-dimensional mapping and therapy of prostate cancer |
EP2888988A4 (en) * | 2012-08-23 | 2016-06-15 | Sbi Pharmaceuticals Co Ltd | Photodynamic diagnosis apparatus provided with collimator |
CN104684398A (en) | 2012-08-31 | 2015-06-03 | 索隆-基特林癌症研究协会 | Particles, methods and uses thereof |
JP6250694B2 (en) * | 2012-11-26 | 2017-12-20 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Spiral biopsy device |
EP2929327B1 (en) | 2012-12-05 | 2019-08-14 | Perimeter Medical Imaging, Inc. | System and method for wide field oct imaging |
EP2934600A4 (en) | 2012-12-19 | 2016-08-17 | Sloan Kettering Inst Cancer | Multimodal particles, methods and uses thereof |
JP6635791B2 (en) * | 2013-02-20 | 2020-01-29 | スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ | Wide-field Raman imaging apparatus and related method |
US9526579B2 (en) * | 2013-03-12 | 2016-12-27 | Boston Scientific Scimed, Inc. | Combination diffused and focused fiber optic for diagnosis and treatment of diseased cells |
CN105283117B (en) * | 2013-03-15 | 2020-06-30 | 德普伊新特斯产品公司 | Calibration using distal end cap |
ES2961685T3 (en) | 2013-03-15 | 2024-03-13 | Hologic Inc | System and method of review and analysis of cytological samples |
JP5988907B2 (en) * | 2013-03-27 | 2016-09-07 | オリンパス株式会社 | Endoscope system |
CN105208936B (en) | 2013-03-29 | 2018-09-14 | 通用电气公司 | Mammography apparatus and the method for controlling its position alignment |
US10531862B2 (en) | 2013-06-26 | 2020-01-14 | General Electric Company | System and method for attaching a biopsy collecting device to a spectroscopy system |
US9913628B2 (en) | 2013-06-26 | 2018-03-13 | General Electric Company | System and method for attaching a biopsy collecting device to a spectroscopy system |
US9572591B2 (en) | 2013-09-03 | 2017-02-21 | United States Endoscopy Group, Inc. | Endoscopic snare device |
US9872700B2 (en) | 2013-09-03 | 2018-01-23 | United States Endoscopy Group, Inc. | Endoscopic snare device |
JP6737705B2 (en) | 2013-11-14 | 2020-08-12 | ザ・ジョージ・ワシントン・ユニバーシティThe George Washingtonuniversity | Method of operating system for determining depth of injury site and system for generating images of heart tissue |
JP2017500550A (en) | 2013-11-20 | 2017-01-05 | ザ・ジョージ・ワシントン・ユニバーシティThe George Washingtonuniversity | System and method for hyperspectral analysis of cardiac tissue |
US10912947B2 (en) | 2014-03-04 | 2021-02-09 | Memorial Sloan Kettering Cancer Center | Systems and methods for treatment of disease via application of mechanical force by controlled rotation of nanoparticles inside cells |
EP3180038A4 (en) | 2014-07-28 | 2018-04-04 | Memorial Sloan-Kettering Cancer Center | Metal(loid) chalcogen nanoparticles as universal binders for medical isotopes |
KR102499045B1 (en) | 2014-11-03 | 2023-02-10 | 더 조지 워싱턴 유니버시티 | Systems and methods for lesion assessment |
JP6771731B2 (en) | 2014-11-03 | 2020-10-21 | 460メディカル・インコーポレイテッド460Medical, Inc. | Contact evaluation system and method |
WO2016149701A1 (en) | 2015-03-19 | 2016-09-22 | The Regents Of The University Of Michigan | System for analyzing tissue |
US10919089B2 (en) | 2015-07-01 | 2021-02-16 | Memorial Sloan Kettering Cancer Center | Anisotropic particles, methods and uses thereof |
EP3319524A4 (en) * | 2015-07-07 | 2019-03-06 | Precision Biopsy, Inc. | Motorized optical imaging of prostate cancer |
US10779904B2 (en) | 2015-07-19 | 2020-09-22 | 460Medical, Inc. | Systems and methods for lesion formation and assessment |
US10537225B2 (en) * | 2016-11-28 | 2020-01-21 | Olympus Corporation | Marking method and resecting method |
AU2017375435B2 (en) * | 2016-12-15 | 2022-02-17 | Gemological Institute Of America, Inc. (Gia) | Device and method for screening gemstones |
EP3565487B1 (en) | 2017-01-09 | 2024-03-06 | United States Endoscopy Group, Inc. | Retrieval device |
US10806334B2 (en) * | 2017-02-28 | 2020-10-20 | Verily Life Sciences Llc | System and method for multiclass classification of images using a programmable light source |
US11071458B2 (en) * | 2017-06-30 | 2021-07-27 | Agency For Science, Technology And Research | SERS-active opto-fluidic photonic crystal fiber probe as biopsy needle and optofluidic sensor |
EP3655748B1 (en) | 2017-07-18 | 2023-08-09 | Perimeter Medical Imaging, Inc. | Sample container for stabilizing and aligning excised biological tissue samples for ex vivo analysis |
EP3540494B1 (en) | 2018-03-16 | 2022-11-23 | Leica Instruments (Singapore) Pte. Ltd. | Augmented reality surgical microscope and microscopy method |
EP3852603A4 (en) | 2018-11-05 | 2022-06-22 | Medivators Inc. | Endoscope cleaning and inspection system and method |
WO2020096894A1 (en) * | 2018-11-05 | 2020-05-14 | Medivators Inc. | Endoscope fluorescence inspection device |
EP3730042A1 (en) * | 2019-02-07 | 2020-10-28 | Canon U.S.A., Inc. | Apparatus for reducing thermal noise and ambient light noise in fluorescence imaging |
GB2601789A (en) * | 2020-12-10 | 2022-06-15 | Creo Medical Ltd | Raman spectroscopy probe, Raman spectroscopy apparatus including the Raman spectroscopy probe and elongate assembly |
DE102021204906A1 (en) | 2021-05-14 | 2022-11-17 | Richard Wolf Gmbh | biopsy system |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0512965A1 (en) * | 1991-05-08 | 1992-11-11 | Xillix Technologies Corporation | Endoscopic imaging system for diseased tissue |
US5383467A (en) | 1992-11-18 | 1995-01-24 | Spectrascience, Inc. | Guidewire catheter and apparatus for diagnostic imaging |
US5431645A (en) * | 1990-05-10 | 1995-07-11 | Symbiosis Corporation | Remotely activated endoscopic tools such as endoscopic biopsy forceps |
US5439000A (en) | 1992-11-18 | 1995-08-08 | Spectrascience, Inc. | Method of diagnosing tissue with guidewire |
DE19533856A1 (en) * | 1995-09-13 | 1997-03-20 | Balazs Mattias | Instrument for carrying out operations by minimal invasive techniques |
WO1997032182A1 (en) * | 1996-02-27 | 1997-09-04 | Massachusetts Institute Of Technology | Method and apparatus for performing optical measurements using a fiber optic imaging guidewire, catheter or endoscope |
WO1997041777A1 (en) * | 1996-05-07 | 1997-11-13 | The General Hospital Corporation | Optical biopsy forceps and methods of diagnosing tissue |
US5762613A (en) | 1996-05-07 | 1998-06-09 | Spectrascience, Inc. | Optical biopsy forceps |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5933388B2 (en) | 1976-03-19 | 1984-08-15 | 高美 上原 | Single-operable biopsy fiberscope |
US4479499A (en) | 1982-01-29 | 1984-10-30 | Alfano Robert R | Method and apparatus for detecting the presence of caries in teeth using visible light |
WO1983003189A1 (en) | 1982-03-16 | 1983-09-29 | Laserscope Inc | Surgical device for internal operations |
JPS5940830A (en) | 1982-08-31 | 1984-03-06 | 浜松ホトニクス株式会社 | Apparatus for diagnosis of cancer using laser beam pulse |
US5139025A (en) | 1983-10-14 | 1992-08-18 | Somanetics Corporation | Method and apparatus for in vivo optical spectroscopic examination |
JPS60209146A (en) * | 1984-03-31 | 1985-10-21 | Olympus Optical Co Ltd | Fluorescence spectrochemical analysis device |
US4651201A (en) * | 1984-06-01 | 1987-03-17 | Arnold Schoolman | Stereoscopic endoscope arrangement |
US5125404A (en) | 1985-03-22 | 1992-06-30 | Massachusetts Institute Of Technology | Apparatus and method for obtaining spectrally resolved spatial images of tissue |
US5199431A (en) | 1985-03-22 | 1993-04-06 | Massachusetts Institute Of Technology | Optical needle for spectroscopic diagnosis |
US4718417A (en) | 1985-03-22 | 1988-01-12 | Massachusetts Institute Of Technology | Visible fluorescence spectral diagnostic for laser angiosurgery |
US5318024A (en) | 1985-03-22 | 1994-06-07 | Massachusetts Institute Of Technology | Laser endoscope for spectroscopic imaging |
US5104392A (en) | 1985-03-22 | 1992-04-14 | Massachusetts Institute Of Technology | Laser spectro-optic imaging for diagnosis and treatment of diseased tissue |
US5106387A (en) | 1985-03-22 | 1992-04-21 | Massachusetts Institute Of Technology | Method for spectroscopic diagnosis of tissue |
CN85100424B (en) | 1985-04-01 | 1986-10-29 | 上海医疗器械研究所 | Inherent fluorescence diagnostic instrument for malignant tumor |
AT387860B (en) | 1985-09-16 | 1989-03-28 | Optical Sensing Technology | METHOD AND DEVICE FOR TUMOR DIAGNOSIS BY MEANS OF SERA |
US5042494A (en) | 1985-11-13 | 1991-08-27 | Alfano Robert R | Method and apparatus for detecting cancerous tissue using luminescence excitation spectra |
US4895156A (en) | 1986-07-02 | 1990-01-23 | Schulze John E | Sensor system using fluorometric decay measurements |
US4981138A (en) | 1988-06-30 | 1991-01-01 | Yale University | Endoscopic fiberoptic fluorescence spectrometer |
US4972331A (en) | 1989-02-06 | 1990-11-20 | Nim, Inc. | Phase modulated spectrophotometry |
US5402778A (en) | 1993-01-19 | 1995-04-04 | Nim Incorporated | Spectrophotometric examination of tissue of small dimension |
US5596987A (en) | 1988-11-02 | 1997-01-28 | Noninvasive Technology, Inc. | Optical coupler for in vivo examination of biological tissue |
US5122974A (en) | 1989-02-06 | 1992-06-16 | Nim, Inc. | Phase modulated spectrophotometry |
US5555885A (en) | 1988-12-21 | 1996-09-17 | Non-Invasive Technology, Inc. | Examination of breast tissue using time-resolved spectroscopy |
US5187672A (en) | 1989-02-06 | 1993-02-16 | Nim Incorporated | Phase modulation spectroscopic system |
WO1990006718A1 (en) | 1988-12-21 | 1990-06-28 | Massachusetts Institute Of Technology | A method for laser induced fluorescence of tissue |
US5353799A (en) | 1991-01-22 | 1994-10-11 | Non Invasive Technology, Inc. | Examination of subjects using photon migration with high directionality techniques |
US5553614A (en) | 1988-12-21 | 1996-09-10 | Non-Invasive Technology, Inc. | Examination of biological tissue using frequency domain spectroscopy |
US5386827A (en) | 1993-03-30 | 1995-02-07 | Nim Incorporated | Quantitative and qualitative in vivo tissue examination using time resolved spectroscopy |
SE8900612D0 (en) | 1989-02-22 | 1989-02-22 | Jonas Johansson | TISSUE CHARACTERIZATION USING A BLOOD-FREE FLUORESCENCE CRITERIA |
US5421337A (en) | 1989-04-14 | 1995-06-06 | Massachusetts Institute Of Technology | Spectral diagnosis of diseased tissue |
US5201318A (en) | 1989-04-24 | 1993-04-13 | Rava Richard P | Contour mapping of spectral diagnostics |
US5369496A (en) | 1989-11-13 | 1994-11-29 | Research Foundation Of City College Of New York | Noninvasive method and apparatus for characterizing biological materials |
JP2852774B2 (en) | 1989-11-22 | 1999-02-03 | 株式会社エス・エル・ティ・ジャパン | Diagnostic device for living tissue and treatment device provided with the diagnostic device |
US5131398A (en) | 1990-01-22 | 1992-07-21 | Mediscience Technology Corp. | Method and apparatus for distinguishing cancerous tissue from benign tumor tissue, benign tissue or normal tissue using native fluorescence |
US5062428A (en) | 1990-06-04 | 1991-11-05 | Nim Incorporated | Method and device for in vivo diagnosis detecting IR emission by body organ |
DE69132273D1 (en) | 1990-10-10 | 2000-08-03 | Univ Maryland | METHOD AND DEVICE FOR DETERMINING THE LIFETIME OF FLUORESCENCE IN FLOW CYTOMETRY |
EP0568596A1 (en) | 1991-01-24 | 1993-11-10 | The University Of Maryland | Method and apparatus for multi-dimensional phase fluorescence lifetime imaging |
US5168162A (en) | 1991-02-04 | 1992-12-01 | Cornell Research Foundation, Inc. | Method of detecting the presence of anomalies in exfoliated cells using infrared spectroscopy |
US5261410A (en) | 1991-02-07 | 1993-11-16 | Alfano Robert R | Method for determining if a tissue is a malignant tumor tissue, a benign tumor tissue, or a normal or benign tissue using Raman spectroscopy |
US5303026A (en) | 1991-02-26 | 1994-04-12 | The Regents Of The University Of California Los Alamos National Laboratory | Apparatus and method for spectroscopic analysis of scattering media |
US5318023A (en) | 1991-04-03 | 1994-06-07 | Cedars-Sinai Medical Center | Apparatus and method of use for a photosensitizer enhanced fluorescence based biopsy needle |
US5293872A (en) * | 1991-04-03 | 1994-03-15 | Alfano Robert R | Method for distinguishing between calcified atherosclerotic tissue and fibrous atherosclerotic tissue or normal cardiovascular tissue using Raman spectroscopy |
US5377676A (en) | 1991-04-03 | 1995-01-03 | Cedars-Sinai Medical Center | Method for determining the biodistribution of substances using fluorescence spectroscopy |
US5465147A (en) | 1991-04-29 | 1995-11-07 | Massachusetts Institute Of Technology | Method and apparatus for acquiring images using a ccd detector array and no transverse scanner |
DE69227902T3 (en) | 1991-04-29 | 2010-04-22 | Massachusetts Institute Of Technology, Cambridge | DEVICE FOR OPTICAL IMAGING AND MEASUREMENT |
US5196709A (en) | 1991-05-03 | 1993-03-23 | University Of Maryland Systems | Fluorometry method and apparatus using a semiconductor laser diode as a light source |
US5203328A (en) | 1991-07-17 | 1993-04-20 | Georgia Tech Research Corporation | Apparatus and methods for quantitatively measuring molecular changes in the ocular lens |
US5348018A (en) | 1991-11-25 | 1994-09-20 | Alfano Robert R | Method for determining if tissue is malignant as opposed to non-malignant using time-resolved fluorescence spectroscopy |
US5467767A (en) | 1991-11-25 | 1995-11-21 | Alfano; Robert R. | Method for determining if tissue is malignant as opposed to non-malignant using time-resolved fluorescence spectroscopy |
US5635402A (en) | 1992-03-05 | 1997-06-03 | Alfano; Robert R. | Technique for determining whether a cell is malignant as opposed to non-malignant using extrinsic fluorescence spectroscopy |
US5350375A (en) | 1993-03-15 | 1994-09-27 | Yale University | Methods for laser induced fluorescence intensity feedback control during laser angioplasty |
US5413108A (en) | 1993-04-21 | 1995-05-09 | The Research Foundation Of City College Of New York | Method and apparatus for mapping a tissue sample for and distinguishing different regions thereof based on luminescence measurements of cancer-indicative native fluorophor |
US5349964A (en) | 1993-05-05 | 1994-09-27 | Intelliwire, Inc. | Device having an electrically actuatable section with a portion having a current shunt and method |
US5421339A (en) | 1993-05-12 | 1995-06-06 | Board Of Regents, The University Of Texas System | Diagnosis of dysplasia using laser induced fluoroescence |
US5673701A (en) | 1994-10-07 | 1997-10-07 | Non Invasive Technology, Inc. | Optical techniques for examination of biological tissue |
US5474910A (en) | 1993-10-15 | 1995-12-12 | Alfano; Robert R. | Method and device for detecting biological molecules and/or microorganisms within a desired area or space |
US5408966A (en) | 1993-12-23 | 1995-04-25 | Ford Motor Company | System and method for synchronously activating cylinders within a variable displacement engine |
US5590660A (en) | 1994-03-28 | 1997-01-07 | Xillix Technologies Corp. | Apparatus and method for imaging diseased tissue using integrated autofluorescence |
US5650135A (en) | 1994-07-01 | 1997-07-22 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive localization of a light-emitting conjugate in a mammal |
US5599717A (en) | 1994-09-02 | 1997-02-04 | Martin Marietta Energy Systems, Inc. | Advanced synchronous luminescence system |
US5579773A (en) | 1994-09-30 | 1996-12-03 | Martin Marietta Energy Systems, Inc. | Laser-induced differential normalized fluorescence method for cancer diagnosis |
JPH08224240A (en) * | 1995-02-22 | 1996-09-03 | Olympus Optical Co Ltd | Fluorescent diagnosing device |
US5612540A (en) | 1995-03-31 | 1997-03-18 | Board Of Regents, The University Of Texas Systems | Optical method for the detection of cervical neoplasias using fluorescence spectroscopy |
IT1277690B1 (en) * | 1995-12-22 | 1997-11-11 | Bieffe Medital Spa | VERTEBRAL SUPPORT AND IMPLEMENTATION SYSTEM IN PARTICULAR FOR SURGICAL AND DIAGNOSTIC INSTRUMENTS |
US5647368A (en) | 1996-02-28 | 1997-07-15 | Xillix Technologies Corp. | Imaging system for detecting diseased tissue using native fluorsecence in the gastrointestinal and respiratory tract |
-
1998
- 1998-03-09 US US09/037,722 patent/US6174291B1/en not_active Expired - Lifetime
-
1999
- 1999-03-09 JP JP2000535257A patent/JP4477230B2/en not_active Expired - Lifetime
- 1999-03-09 CA CA002322768A patent/CA2322768C/en not_active Expired - Fee Related
- 1999-03-09 AT AT99913840T patent/ATE412363T1/en not_active IP Right Cessation
- 1999-03-09 DE DE69939818T patent/DE69939818D1/en not_active Expired - Lifetime
- 1999-03-09 DE DE69942624T patent/DE69942624D1/en not_active Expired - Lifetime
- 1999-03-09 AT AT08016179T patent/ATE474498T1/en not_active IP Right Cessation
- 1999-03-09 EP EP99913840A patent/EP1065970B1/en not_active Expired - Lifetime
- 1999-03-09 EP EP08016179A patent/EP2018824B1/en not_active Expired - Lifetime
- 1999-03-09 WO PCT/US1999/005134 patent/WO1999045838A1/en active Application Filing
-
2009
- 2009-12-18 JP JP2009288017A patent/JP2010088929A/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5431645A (en) * | 1990-05-10 | 1995-07-11 | Symbiosis Corporation | Remotely activated endoscopic tools such as endoscopic biopsy forceps |
EP0512965A1 (en) * | 1991-05-08 | 1992-11-11 | Xillix Technologies Corporation | Endoscopic imaging system for diseased tissue |
US5507287A (en) | 1991-05-08 | 1996-04-16 | Xillix Technologies Corporation | Endoscopic imaging system for diseased tissue |
US5383467A (en) | 1992-11-18 | 1995-01-24 | Spectrascience, Inc. | Guidewire catheter and apparatus for diagnostic imaging |
US5439000A (en) | 1992-11-18 | 1995-08-08 | Spectrascience, Inc. | Method of diagnosing tissue with guidewire |
US5601087A (en) | 1992-11-18 | 1997-02-11 | Spectrascience, Inc. | System for diagnosing tissue with guidewire |
DE19533856A1 (en) * | 1995-09-13 | 1997-03-20 | Balazs Mattias | Instrument for carrying out operations by minimal invasive techniques |
WO1997032182A1 (en) * | 1996-02-27 | 1997-09-04 | Massachusetts Institute Of Technology | Method and apparatus for performing optical measurements using a fiber optic imaging guidewire, catheter or endoscope |
WO1997041777A1 (en) * | 1996-05-07 | 1997-11-13 | The General Hospital Corporation | Optical biopsy forceps and methods of diagnosing tissue |
US5762613A (en) | 1996-05-07 | 1998-06-09 | Spectrascience, Inc. | Optical biopsy forceps |
Non-Patent Citations (2)
Title |
---|
"subset selection in regression,", 1990, CHAPMAN HALL, LONDON, article MILLER.A.J., pages: 229 |
SCHOMACKER ET AL,: ""Ultraviolet laser-induced fluorescence of colonic tissue: Basic biology and diagnostic potential", LASERS INSURGERY AND MEDICINE,, vol. 12, 1992, pages 63 - 78 |
Cited By (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1089067A3 (en) * | 1999-09-29 | 2002-05-29 | Fuji Photo Film Co., Ltd. | Method of and apparatus for obtaining fluorescence image |
US6492646B1 (en) | 1999-09-29 | 2002-12-10 | Fuji Photo Film Co., Ltd. | Method of and apparatus for obtaining fluorescence image |
EP1089067A2 (en) * | 1999-09-29 | 2001-04-04 | Fuji Photo Film Co., Ltd. | Method of and apparatus for obtaining fluorescence image |
EP1229836A1 (en) * | 1999-11-05 | 2002-08-14 | SPECTRX, Inc. | Multi-modal optical tissue diagnostic system |
EP1229836A4 (en) * | 1999-11-05 | 2007-05-02 | Spectrx Inc | Multi-modal optical tissue diagnostic system |
WO2002048692A1 (en) * | 2000-12-13 | 2002-06-20 | Medical Research Council | Apparatus and method for imaging a histological sample |
EP1670348A1 (en) * | 2003-09-16 | 2006-06-21 | Perceptronix Medical Inc. | Automated endoscopy device, diagnostic method and uses |
EP1670348A4 (en) * | 2003-09-16 | 2009-02-25 | Perceptronix Medical Inc | Automated endoscopy device, diagnostic method and uses |
US9763623B2 (en) | 2004-08-24 | 2017-09-19 | The General Hospital Corporation | Method and apparatus for imaging of vessel segments |
WO2007047033A2 (en) * | 2005-10-18 | 2007-04-26 | Boston Scientific Scimed, Inc. | Method of using an imaging catheter to conduct photodynamic procedures |
WO2007047033A3 (en) * | 2005-10-18 | 2007-06-21 | Boston Scient Scimed Inc | Method of using an imaging catheter to conduct photodynamic procedures |
US7901441B2 (en) | 2005-10-18 | 2011-03-08 | Boston Scientific Scimed, Inc. | Method of using an imaging catheter to conduct photodynamic procedures |
US9516997B2 (en) | 2006-01-19 | 2016-12-13 | The General Hospital Corporation | Spectrally-encoded endoscopy techniques, apparatus and methods |
US9186066B2 (en) | 2006-02-01 | 2015-11-17 | The General Hospital Corporation | Apparatus for applying a plurality of electro-magnetic radiations to a sample |
US10426548B2 (en) | 2006-02-01 | 2019-10-01 | The General Hosppital Corporation | Methods and systems for providing electromagnetic radiation to at least one portion of a sample using conformal laser therapy procedures |
USRE46412E1 (en) | 2006-02-24 | 2017-05-23 | The General Hospital Corporation | Methods and systems for performing angle-resolved Fourier-domain optical coherence tomography |
WO2008011056A3 (en) * | 2006-07-18 | 2008-07-03 | Univ Boston | Device with integrated multi-fiber optical probe and methods of use |
WO2008011056A2 (en) * | 2006-07-18 | 2008-01-24 | Trustees Of Boston University, Et Al. | Device with integrated multi-fiber optical probe and methods of use |
US9968245B2 (en) | 2006-10-19 | 2018-05-15 | The General Hospital Corporation | Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s) |
US10835110B2 (en) | 2008-07-14 | 2020-11-17 | The General Hospital Corporation | Apparatus and method for facilitating at least partial overlap of dispersed ration on at least one sample |
US9615748B2 (en) | 2009-01-20 | 2017-04-11 | The General Hospital Corporation | Endoscopic biopsy apparatus, system and method |
US11490826B2 (en) | 2009-07-14 | 2022-11-08 | The General Hospital Corporation | Apparatus, systems and methods for measuring flow and pressure within a vessel |
US9642531B2 (en) | 2010-03-05 | 2017-05-09 | The General Hospital Corporation | Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution |
US10463254B2 (en) | 2010-03-05 | 2019-11-05 | The General Hospital Corporation | Light tunnel and lens which provide extended focal depth of at least one anatomical structure at a particular resolution |
US9408539B2 (en) | 2010-03-05 | 2016-08-09 | The General Hospital Corporation | Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution |
US9069130B2 (en) | 2010-05-03 | 2015-06-30 | The General Hospital Corporation | Apparatus, method and system for generating optical radiation from biological gain media |
US9951269B2 (en) | 2010-05-03 | 2018-04-24 | The General Hospital Corporation | Apparatus, method and system for generating optical radiation from biological gain media |
US9557154B2 (en) | 2010-05-25 | 2017-01-31 | The General Hospital Corporation | Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions |
US9795301B2 (en) | 2010-05-25 | 2017-10-24 | The General Hospital Corporation | Apparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images |
US10939825B2 (en) | 2010-05-25 | 2021-03-09 | The General Hospital Corporation | Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions |
US10285568B2 (en) | 2010-06-03 | 2019-05-14 | The General Hospital Corporation | Apparatus and method for devices for imaging structures in or at one or more luminal organs |
US9510758B2 (en) | 2010-10-27 | 2016-12-06 | The General Hospital Corporation | Apparatus, systems and methods for measuring blood pressure within at least one vessel |
US9629528B2 (en) | 2012-03-30 | 2017-04-25 | The General Hospital Corporation | Imaging system, method and distal attachment for multidirectional field of view endoscopy |
US11490797B2 (en) | 2012-05-21 | 2022-11-08 | The General Hospital Corporation | Apparatus, device and method for capsule microscopy |
US9415550B2 (en) | 2012-08-22 | 2016-08-16 | The General Hospital Corporation | System, method, and computer-accessible medium for fabrication miniature endoscope using soft lithography |
US9968261B2 (en) | 2013-01-28 | 2018-05-15 | The General Hospital Corporation | Apparatus and method for providing diffuse spectroscopy co-registered with optical frequency domain imaging |
US10893806B2 (en) | 2013-01-29 | 2021-01-19 | The General Hospital Corporation | Apparatus, systems and methods for providing information regarding the aortic valve |
US11179028B2 (en) | 2013-02-01 | 2021-11-23 | The General Hospital Corporation | Objective lens arrangement for confocal endomicroscopy |
AU2019226243B2 (en) * | 2013-03-12 | 2020-06-04 | Lawrence Livermore National Security, Llc | Assessment of tissue or lesion depth using temporally resolved light scattering spectroscopy |
US10478072B2 (en) | 2013-03-15 | 2019-11-19 | The General Hospital Corporation | Methods and system for characterizing an object |
US9784681B2 (en) | 2013-05-13 | 2017-10-10 | The General Hospital Corporation | System and method for efficient detection of the phase and amplitude of a periodic modulation associated with self-interfering fluorescence |
US10117576B2 (en) | 2013-07-19 | 2018-11-06 | The General Hospital Corporation | System, method and computer accessible medium for determining eye motion by imaging retina and providing feedback for acquisition of signals from the retina |
US11452433B2 (en) | 2013-07-19 | 2022-09-27 | The General Hospital Corporation | Imaging apparatus and method which utilizes multidirectional field of view endoscopy |
US10058250B2 (en) | 2013-07-26 | 2018-08-28 | The General Hospital Corporation | System, apparatus and method for utilizing optical dispersion for fourier-domain optical coherence tomography |
US9733460B2 (en) | 2014-01-08 | 2017-08-15 | The General Hospital Corporation | Method and apparatus for microscopic imaging |
US10736494B2 (en) | 2014-01-31 | 2020-08-11 | The General Hospital Corporation | System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device |
US10228556B2 (en) | 2014-04-04 | 2019-03-12 | The General Hospital Corporation | Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s) |
CN104000530A (en) * | 2014-06-06 | 2014-08-27 | 李香秀 | Temporary hand-washing device |
US10912462B2 (en) | 2014-07-25 | 2021-02-09 | The General Hospital Corporation | Apparatus, devices and methods for in vivo imaging and diagnosis |
US11234600B2 (en) * | 2017-07-13 | 2022-02-01 | The Board Of Regents For Oklahoma State University | System and method for tissue visualization |
WO2020112500A1 (en) * | 2018-11-30 | 2020-06-04 | Verily Life Sciences Llc | Endoscopic systems including a multimode optical fiber and a machine learning classifier for interrogating a portion of a body |
WO2022246117A1 (en) * | 2021-05-21 | 2022-11-24 | Dermasensor, Inc. | Dynamic calibration of light intensity in a system for non-invasive detection of skin cancer using elastic scattering spectroscopy |
Also Published As
Publication number | Publication date |
---|---|
CA2322768A1 (en) | 1999-09-16 |
JP4477230B2 (en) | 2010-06-09 |
EP1065970B1 (en) | 2008-10-29 |
CA2322768C (en) | 2008-08-05 |
US6174291B1 (en) | 2001-01-16 |
JP2010088929A (en) | 2010-04-22 |
EP2018824B1 (en) | 2010-07-21 |
EP1065970A1 (en) | 2001-01-10 |
EP2018824A1 (en) | 2009-01-28 |
DE69939818D1 (en) | 2008-12-11 |
ATE412363T1 (en) | 2008-11-15 |
DE69942624D1 (en) | 2010-09-02 |
JP2002505900A (en) | 2002-02-26 |
ATE474498T1 (en) | 2010-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2018824B1 (en) | Optical biopsy system | |
US10939864B2 (en) | Falloposcope and method for ovarian cancer detection | |
AU2001251164B2 (en) | Methods and apparatus for diagnostic multispectral digital imaging | |
US20060293556A1 (en) | Endoscope with remote control module or camera | |
US6697652B2 (en) | Fluorescence, reflectance and light scattering spectroscopy for measuring tissue | |
US20030167007A1 (en) | Apparatus and method for spectroscopic examination of the colon | |
US20060217594A1 (en) | Endoscopy device with removable tip | |
US20070015989A1 (en) | Endoscope Image Recognition System and Method | |
US20060141633A1 (en) | Method and system for characterization and mapping of tissue lesions | |
JPH08224240A (en) | Fluorescent diagnosing device | |
EP2814375B1 (en) | Photonic probe apparatus with integrated tissue marking facility | |
US7712901B2 (en) | Method and apparatus for diagnosing conditions of the eye with infrared light | |
EP2223646A1 (en) | Biological observation apparatus and endoscopic apparatus | |
JPH0654792A (en) | Image pickup device | |
WO2009144653A2 (en) | Needle with integrated photon detector | |
JPH09327433A (en) | Imaging system to detect affected tissue using specific fluorescence in gastrointestine and respiratory tract | |
JP2009543663A (en) | Apparatus with integrated multi-fiber optical probe and method of use | |
JPWO2012132571A1 (en) | Diagnostic system | |
US20160030022A1 (en) | Optical Biopsy Needle and Endoscope System | |
JP2001095750A (en) | Fluorescence identification and equipment | |
WO2012048890A1 (en) | Probe head device and method for enhanced diagnostics | |
JP2002543907A (en) | Optical biopsy system | |
RU2152162C1 (en) | Method for increasing accuracy in detecting malignant neoplasms and determining their localization boundaries | |
WO2022236294A1 (en) | Cancer diagnostic device | |
JP2005305182A (en) | Optical diagnostic apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2322768 Country of ref document: CA Ref country code: CA Ref document number: 2322768 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 535257 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999913840 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999913840 Country of ref document: EP |